Heart failure and antihypertensive medication

I9_HEARTFAIL_AND_ANTIHYPERT

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions RX_ANTIHYP	295206
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints I9_HEARTFAIL	40872
6. Filter based on genotype QC (FinnGen only)	39771

Control definitions (FinnGen only)

Control conditions: not RX_ANTIHYP

Extra metadata

First used in FinnGen datafreeze: DF5

NAME	I9_HEARTFAIL_AND_ANTIHYPERT
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS	!RX_ANTIHYP
SEX
INCLUDE	I9_HEARTFAIL
PRE_CONDITIONS
CONDITIONS	RX_ANTIHYP
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Heart failure and antihypertensive medication based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	392255	208935	178711
Only index persons	291613	157423	134190
Unadjusted period prevalence (%)
Whole population	5.52	5.98	4.99
Only index persons	5.48	5.79	5.12
Median age at first event (years)
Whole population	74.28	76.57	71.66
Only index persons	74.82	77.32	71.88

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	39771	15706	24065
Unadjusted period prevalence (%)	8.87	5.57	11.02
Median age at first event (years)	71.70	72.47	71.20

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
13059: Matched controls
85392

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.4

323.3

1430

2967

N02AA05

ATC

oxycodone; systemic

2.6

322.7

2567

7454

Z3226

NOMESCO Finland

Physiotherapist

2.6

322.1

2481

7089

WX408

NOMESCO Finland

General anesthesy, balanced

2.3

322.0

3482

11651

C03BA11

ATC

indapamide; oral

28.6

321.4

299

C09DB01

ATC

valsartan and amlodipine; oral

47.1

320.3

268

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.1

316.5

4435

16497

FNC10

NOMESCO Finland

Aorto-coronary venous bypass with single distal anastomosis

85.9

316.3

245

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

85.9

316.3

245

XG466

NOMESCO Finland

Sleep oxymetry

6.7

314.8

621

636

K76

ICPC

Ischaemic heart dis without angina

29.4

314.0

290

H3601, E113,

ICD-10 Finland

33.4

312.8

280

Z2221

NOMESCO Finland

Medical doctor

2.3

312.3

3428

11522

A10AB04

ATC

insulin lispro; parenteral

8.7

312.1

497

386

C10AA03

ATC

pravastatin; oral

4.7

310.4

865

1258

JN3AD

NOMESCO Finland

Abdominal CT examination

3.1

309.9

1660

3883

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

15.1

308.4

359

160

I49.3

ICD-10 Finland

Ventricular premature depolarization

4.9

308.0

827

1163

A10AA02, ,

ATC

7.3

307.9

562

524

FNC30

NOMESCO Finland

Aorto-coronary venous bypass with three distal anastomoses

93.1

307.7

265

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

5.6

307.7

1143

1432

C07AB02

ATC

metoprolol; systemic

26.6

307.7

3336

1089

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

7.6

307.7

1093

1014

A12BA01

ATC

potassium chloride; oral

29.1

307.7

916

221

A08

ICPC

Swelling

6.4

307.7

865

941

J01FF01

ATC

clindamycin; systemic

2.6

307.7

3912

12124

AN3

Balloon angioplasty and metallic stent

40.9

307.7

389

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

51.9

307.7

393

I20.99

ICD-10 Finland

Angina pectoris, unspecified

14.1

307.7

1157

586

Z49.0

ICD-10 Finland

Preparatory care for dialysis

189.8

307.7

284

N19

ICD-10 Finland

Unspecified kidney failure

19.2

307.7

782

283

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

5.3

307.7

912

1188

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

18.6

307.7

408

148

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

14.3

307.7

980

482

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

42.9

307.7

1694

296

XF402

NOMESCO Finland

ECG with work load test

6.2

307.7

1689

1992

K87

ICPC

Hypertension complicated

58.3

307.7

288

R02

ICPC

Shortness of breath/dyspnoea

5.6

307.7

2410

3299

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

4.9

307.7

1533

2271

XCK10

NOMESCO Finland

Photography of fundus of eye

4.1

307.7

1396

2398

C07AB12

ATC

nebivolol; oral

40.1

307.7

300

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

5.9

307.7

1031

1223

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

4.2

307.7

2064

3640

R53

ICD-10 Finland

Malaise and fatigue

2.5

307.7

2835

8385

T90

ICPC

Diabetes non-insulin dependent

7.9

307.7

4080

4641

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

14.7

307.7

589

274

FNC20

NOMESCO Finland

Aorto-coronary venous bypass with two distal anastomoses

102.5

307.7

336

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

8.4

307.7

3150

3118

I44.2

ICD-10 Finland

Atrioventricular block, complete

16.5

307.7

609

253

C08CA13

ATC

lercanidipine; oral

137.1

307.7

1932

108

C08DA01

ATC

verapamil; systemic

20.7

307.7

600

198

C08CA05

ATC

nifedipine; systemic

11.4

307.7

809

490

R03AC02

ATC

salbutamol; inhalant

2.3

307.7

6814

27641

A10BJ02

ATC

liraglutide; parenteral

26.1

307.7

507

132

WX722

NOMESCO Finland

PEEP

7.4

307.7

943

889

XF400

NOMESCO Finland

ECG with 12 standard connections

5.4

307.7

3075

4579

K84

ICPC

Heart disease other

28.0

307.7

582

142

I25.2

ICD-10 Finland

Old myocardial infarction

47.3

307.7

1693

268

C10AA01

ATC

simvastatin; oral

5.2

307.7

6313

12954

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

15.2

307.7

733

333

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

22.7

307.7

1953

655

J18.9

ICD-10 Finland

Pneumonia, unspecified

4.3

307.7

5020

10929

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

22.8

307.7

1190

374

D64.9

ICD-10 Finland

Anaemia, unspecified

5.2

307.7

1938

2785

SPAT1148

SPAT

Treatment of chronic ulcer or burn

4.6

307.7

2268

3723

K77

ICPC

Heart failure

129.7

307.7

766

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

11.2

307.7

1952

1323

GD1AA

NOMESCO Finland

Thorax X-ray examination

6.7

307.7

8636

19344

C09CA03

ATC

valsartan; oral

63.4

307.7

1374

158

E66.00

ICD-10 Finland

Metabolic syndrome

14.1

307.7

1082

542

R07.4

ICD-10 Finland

Chest pain, unspecified

3.2

307.7

3816

9713

C07AB07

ATC

bisoprolol; oral

81.5

307.7

10671

4437

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

35.1

307.7

1317

272

TPH04

NOMESCO Finland

Cathetrisation of vein

3.8

307.7

3719

8124

J01MA12

ATC

levofloxacin; systemic

2.9

307.7

2875

7685

E66.8

ICD-10 Finland

Other obesity

9.3

307.7

897

671

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.8

307.7

2606

6943

C09DA07

ATC

telmisartan and diuretics; oral

129.0

307.7

383

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

8.0

307.7

722

623

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

3.6

307.7

2651

5646

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

2.6

307.7

4022

12479

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

5.0

307.7

3830

6565

R04.0

ICD-10 Finland

Epistaxis

4.9

307.7

1142

1637

Angiography of the heart and coronary arteries

36.0

307.7

1129

224

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

6.5

307.7

3637

4760

B01AB05

ATC

enoxaparin; parenteral

2.8

307.7

4604

14002

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

7.8

307.7

796

709

FM1DG

NOMESCO Finland

Very extensive MRI examination of heart with high intesity magnet

43.7

307.7

557

AA1

Conventional CABG

176.1

307.7

341

E11

ICD-10 Finland

Type 2 diabetes mellitus

6.4

307.7

2354

2833

C09DA06

ATC

candesartan and diuretics; oral

126.7

307.7

749

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

3.3

307.7

3922

9934

127

Kela drug reimbursment

Transplant complication

40.2

307.7

526

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

14.1

307.7

503

242

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.8

307.7

4224

12386

M10.0

ICD-10 Finland

Idiopathic gout

10.7

307.7

618

395

I42.0

ICD-10 Finland

Dilated cardiomyopathy

240.3

307.7

1941

C07AB08

ATC

celiprolol; oral

52.4

307.7

267

C08CA02

ATC

felodipine; oral

88.4

307.7

1412

117

A10AE04

ATC

insulin glargine; parenteral

12.9

307.7

2062

1225

A10BK01

ATC

dapagliflozin; oral

19.2

307.7

1884

742

N18.0

ICD-10 Finland

End-stage renal disease

79.0

307.7

307

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

23.9

307.7

479

136

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

7.5

307.7

1241

1177

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

+∞

307.7

843

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

6.2

307.7

789

878

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

28.0

307.7

1132

288

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

37.8

307.7

2236

464

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

60.6

307.7

542

K99

ICPC

Cardiovascular disease other

10.3

307.7

472

309

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

12.1

307.7

4714

3817

AP1

Catheterization of the left side of the heart

57.1

307.7

332

K85

ICPC

Elevated blood pressure

6.1

307.7

1503

1794

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

79.7

307.7

1095

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

4.2

307.7

2047

3579

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

15.3

307.7

409

180

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

16.0

307.7

6252

4649

215

Kela drug reimbursment

Diabetes, non-insulin-treated

9.1

307.7

4459

4581

A10BA02

ATC

metformin; oral

7.9

307.7

4797

5829

C09DX04

ATC

valsartan and sacubitril; oral

+∞

307.7

826

C09DA03

ATC

valsartan and diuretics; oral

243.0

307.7

466

M10

ICD-10 Finland

Gout

6.2

307.7

692

764

M04AA01

ATC

allopurinol; systemic

9.3

307.7

2926

2580

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

60.1

307.7

688

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.9

307.7

1983

4971

B03XA02

ATC

darbepoetin alfa; parenteral

12.1

307.7

519

291

C10AA04

ATC

fluvastatin; oral

4.6

307.7

995

1507

TPH07

NOMESCO Finland

Cathetrisation of artery

5.8

307.7

2322

3050

381

Kela drug reimbursment

Combination product containing sacubitril and valsartan

+∞

307.7

738

Z94.0

ICD-10 Finland

Kidney transplant status

182.2

307.7

326

SPAT1254

SPAT

Administration of medicine

3.9

307.7

2096

3980

ZXD05

NOMESCO Finland

Urgent procedure

3.9

307.7

4941

11549

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

14.9

307.7

389

176

H02AB06

ATC

prednisolone; systemic

2.7

307.7

6721

24033

E87.6

ICD-10 Finland

Hypokalaemia

8.5

307.7

553

442

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

55.1

307.7

1448

193

SPAT1262

SPAT

Handing over of treatment supplies

5.3

307.7

2837

4247

C07BB07

ATC

bisoprolol and thiazides; systemic

306.5

307.7

410

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

103.3

307.7

884

A12AA04

ATC

calcium carbonate; oral

42.9

307.7

413

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

29.5

307.7

3807

1176

I44.7

ICD-10 Finland

Left bundle-branch block, unspecified

17.6

307.7

525

203

I21.01

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

44.5

307.7

383

TKC20

NOMESCO Finland

Catheterisation of bladder

4.1

307.7

1162

1997

ZXE10

NOMESCO Finland

More than one and less than three hours

2.2

307.7

4673

17451

K07

ICPC

Swollen ankles/oedema

7.7

307.7

746

663

N17.9

ICD-10 Finland

Acute renal failure, unspecified

16.7

307.7

1167

500

A10AB01

ATC

insulin (human); parenteral

8.7

307.7

579

455

SPAT1263

SPAT

Sampling

2.3

307.7

4974

17791

C10AX09

ATC

ezetimibe; oral

5.6

307.7

2271

3108

N02BE01

ATC

paracetamol; systemic, rectal

3.1

307.7

11261

57371

I48.2

ICD-10 Finland

Chronic atrial fibrillation

109.9

307.7

1343

137

Kela drug reimbursment

Uraemia requiring dialysis

155.8

307.7

257

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

37.4

307.7

1466

288

E66.01

ICD-10 Finland

Obesity due to excess calories

8.1

307.7

1437

1280

C09CA07

ATC

telmisartan; oral

27.9

307.7

712

176

XFE00

NOMESCO Finland

Epicardial ultrasonography

13.1

307.7

449

232

M10.9

ICD-10 Finland

Gout, unspecified

10.7

307.7

1455

991

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

71.8

307.7

726

I21.09

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

24.3

307.7

333

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

103.5

307.7

913

A49.9

ICD-10 Finland

Bacterial infection, unspecified

4.8

307.7

2262

3579

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

18.0

307.7

490

185

B01AE07

ATC

dabigatran etexilate; oral

8.9

307.7

586

448

R03BB04

ATC

tiotropium bromide; inhalant

4.4

307.7

1896

3187

C09BA02

ATC

enalapril and diuretics; systemic

291.0

307.7

1138

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

101.6

307.7

734

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

41.1

307.7

525

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

57.4

307.7

900

110

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

17.3

307.7

661

263

I20.00

ICD-10 Finland

Unstable angina

22.3

307.7

464

141

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

79.7

307.7

919

C03DA01

ATC

spironolactone; oral

47.1

307.7

5195

1182

S97

ICPC

Chronic ulcer skin

8.5

307.7

1342

1139

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

31.3

307.7

1913

466

I20.01

ICD-10 Finland

Unstable angina

49.4

307.7

488

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

14.0

307.7

446

215

A28

ICPC

Limited function/disability NOS

4.3

307.7

2718

4933

R5140

NOMESCO Finland

Monitoring the use of the aid

3.6

307.7

1653

3266

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

10.2

307.7

932

639

G47.3

ICD-10 Finland

Sleep apnoea

3.3

307.7

3350

8032

I50

ICD-10 Finland

Heart failure

103.3

307.7

1140

I36.1

ICD-10 Finland

Nonrheumatic tricuspid (valve) insufficiency

39.1

307.7

372

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

62.1

307.7

744

A10BH05

ATC

linagliptin; oral

16.5

307.7

954

407

V03AE01

ATC

polystyrene sulfonate; oral

35.4

307.7

369

C03AA03

ATC

hydrochlorothiazide; oral

22.0

307.7

1360

448

A10BH01

ATC

sitagliptin; oral

9.1

307.7

1573

1270

B01AC06

ATC

acetylsalicylic acid; oral

26.2

307.7

423

109

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

3.1

307.7

1771

4113

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

5.3

307.7

1500

2043

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

16.5

307.7

5159

3253

A10AC01

ATC

insulin (human); parenteral

10.7

307.7

1501

1026

C02AC05

ATC

moxonidine; oral

556.7

307.7

874

C07AB03

ATC

atenolol; systemic

35.5

307.7

874

172

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.9

307.7

2144

5399

I20.90

ICD-10 Finland

Angina pectoris, unspecified

15.1

307.7

548

247

AN4

Balloon angioplasty and drug eluding stent

46.9

307.7

543

SPAT1222

SPAT

Counselling/guidance promoting independent living

3.3

307.7

2059

4613

C01BD01

ATC

amiodarone; systemic

338.2

307.7

1262

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

20.7

307.7

1140

392

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

5.1

307.7

1270

1779

SPAT1097

SPAT

Recording of ECG

3.7

307.7

1912

3759

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

3.4

307.7

1586

3344

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

139.3

307.7

912

I48.1

ICD-10 Finland

Persistent atrial fibrillation

64.6

307.7

1204

134

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

47.4

307.7

4281

870

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

3.5

307.7

1831

3826

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

25.4

307.7

359

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

16.1

307.7

2325

1135

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

26.6

307.7

1330

362

I25

ICD-10 Finland

Chronic ischaemic heart disease

33.5

307.7

634

130

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

10.7

307.7

2059

1462

N18.8

ICD-10 Finland

Other chronic renal failure

55.0

307.7

678

I10

ICD-10 Finland

Essential (primary) hypertension

45.6

307.7

9203

4246

I20.09

ICD-10 Finland

Unstable angina

18.2

307.7

967

374

C09AA02

ATC

enalapril; systemic

66.2

307.7

3231

422

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

81.2

307.7

705

B01AC04

ATC

clopidogrel; oral

11.7

307.7

2999

2114

SPAT1301

SPAT

No procedures

2.3

307.7

3719

12611

PH1AC

NOMESCO Finland

Flebography of over extremity with X-ray

36.3

307.7

419

I25.1

ICD-10 Finland

Atherosclerotic heart disease

20.5

307.7

5138

2619

GD1LA

NOMESCO Finland

43.8

307.7

509

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

17.9

307.7

524

199

ZX120

NOMESCO Finland

Intravenous

3.6

307.7

1678

3392

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

172.1

307.7

408

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

9.6

307.7

4592

4570

TFP34

NOMESCO Finland

Electrophysiological investigation

20.5

307.7

673

226

B01AA03

ATC

warfarin; systemic

17.3

307.7

5282

3219

J01DB01

ATC

cefalexin; oral

2.5

307.7

10354

51833

A11CC03

ATC

alfacalcidol; systemic

31.4

307.7

663

145

103

Kela drug reimbursment

Diabetes, insulin-treated

8.8

307.7

5071

5738

J45.9

ICD-10 Finland

Asthma, unspecified

3.0

307.7

2551

6324

A41.9

ICD-10 Finland

Sepsis, unspecified

6.0

307.7

734

843

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

29.6

307.7

463

106

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

6.4

307.7

2117

2499

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

30.9

307.7

1711

415

FN1BT

NOMESCO Finland

Extensive endovascular dilatation of coronary (PTCA) arteries

79.5

307.7

355

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

8.1

307.7

787

674

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

182.7

307.7

327

C02EA02, ,

ATC

30.8

307.7

608

135

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

24.7

307.7

1868

573

I35.0

ICD-10 Finland

Aortic (valve) stenosis

12.4

307.7

1181

681

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

4.0

307.7

2343

4457

I50.1

ICD-10 Finland

Left ventricular failure

154.9

307.7

3851

230

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

28.1

307.7

1067

270

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

31.1

307.7

570

125

ZXE20

NOMESCO Finland

More than three and less than five hours

3.5

307.7

2143

4551

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

57.7

307.7

606

C08CA01

ATC

amlodipine; oral

57.6

307.7

5836

1181

XF404

NOMESCO Finland

Ambulatory ECG

12.9

307.7

1993

1178

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

6.9

307.7

2153

2375

Coronary artery bypass surgery

79.6

307.7

309

C10AA05

ATC

atorvastatin; oral

4.8

307.7

6393

14178

I50.0

ICD-10 Finland

Congestive heart failure

100.4

307.7

4434

435

I48

ICD-10 Finland

Atrial fibrillation and flutter

32.2

307.7

6063

2238

Z49.1

ICD-10 Finland

Extracorporeal dialysis

91.2

307.7

458

K78

ICPC

Atrial fibrillation/flutter

28.5

307.7

1751

462

L04AD02

ATC

tacrolimus; systemic

57.1

307.7

365

C09AA04

ATC

perindopril; oral

52.5

307.7

728

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

43.6

307.7

3820

802

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

34.2

307.7

470

N02AX02

ATC

tramadol; systemic, rectal

2.4

307.7

5966

22095

C09CA06

ATC

candesartan; oral

15.5

307.7

2588

1343

R60.0

ICD-10 Finland

Localized oedema

4.4

307.7

2012

3363

E66.9

ICD-10 Finland

Obesity, unspecified

10.5

307.7

583

380

XF640, ,

NOMESCO Finland

13.4

307.7

555

281

TFP35

NOMESCO Finland

Electroanatomical mapping

34.2

307.7

297

C01BC04

ATC

flecainide; systemic

36.6

307.7

454

A10AB05

ATC

insulin aspart; parenteral

11.3

307.7

1610

1052

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

19.8

307.7

1034

370

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

17.9

307.7

1013

400

205

Kela drug reimbursment

Chronic hypertension

50.7

307.7

4790

965

R4110

NOMESCO Finland

Physiotherapy

2.6

307.7

4055

12482

WX872

NOMESCO Finland

Intensive care

14.2

307.7

1353

689

A10AE05

ATC

insulin detemir; parenteral

11.8

307.7

1021

609

C08DB01

ATC

diltiazem; oral

53.5

307.7

821

107

C09AA01

ATC

captopril; oral

52.0

307.7

280

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

7.6

307.7

1498

1428

A10BK03

ATC

empagliflozin; oral

14.0

307.7

2104

1153

A02BC02

ATC

pantoprazole; systemic

2.7

307.7

8990

38516

AA1AD

NOMESCO Finland

CT of head and brain

3.8

307.7

4189

9539

B01AC24

ATC

ticagrelor; oral

42.2

307.7

616

100

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

5.7

307.7

1122

1391

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

220.7

307.7

329

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

8.9

307.7

573

436

C03CA01

ATC

furosemide; systemic

59.0

307.7

10576

5751

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

51.8

307.7

1017

139

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

3.5

307.7

1935

4053

AN1

Coronary angiography

35.4

307.7

2788

649

Z3231

NOMESCO Finland

Registered nurse

2.6

307.7

3821

11532

R06.0

ICD-10 Finland

Dyspnoea

6.5

307.7

5499

8544

C07AA07

ATC

sotalol; systemic

42.9

307.7

697

112

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

33.8

307.7

6461

2405

C09DA01

ATC

losartan and diuretics; oral

162.6

307.7

1115

C09AA05

ATC

ramipril; oral

90.9

307.7

6212

844

C07AB05

ATC

betaxolol; oral

53.7

307.7

289

Single vessel balloon catheter extension

98.6

307.7

266

XF600

NOMESCO Finland

Bloodpressure measurement

5.1

307.7

1021

1404

A10BB12

ATC

glimepiride; oral

12.0

307.7

1186

704

C01DA14

ATC

isosorbide mononitrate; oral

21.1

307.7

3052

1217

E87.5

ICD-10 Finland

Hyperkalaemia

25.0

307.7

459

124

TFP20

NOMESCO Finland

Cardiodefibrillation

58.0

307.7

2240

304

I50.9

ICD-10 Finland

Heart failure, unspecified

221.8

307.7

9749

1119

L04AA06

ATC

mycophenolic acid; systemic

21.6

307.7

571

180

TK800

NOMESCO Finland

Hemodialysis

37.5

307.7

773

143

B01AF01

ATC

rivaroxaban; oral

3.7

307.7

1812

3603

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

23.6

307.7

1965

637

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

7.7

307.7

761

684

J96.1

ICD-10 Finland

Chronic respiratory failure

9.9

307.7

621

429

K86

ICPC

Hypertension uncomplicated

20.5

307.7

1142

398

C01AA05

ATC

digoxin; systemic

23.9

307.7

2752

945

WX892

NOMESCO Finland

Monitored bed care

8.0

307.7

1733

1610

C09CA01

ATC

losartan; oral

34.4

307.7

3510

904

I47.2

ICD-10 Finland

Ventricular tachycardia

67.0

307.7

736

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

43.8

307.7

614

H25.1

ICD-10 Finland

Senile nuclear cataract

2.4

307.7

3257

10441

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

2.8

307.7

2808

7590

B01AF02

ATC

apixaban; oral

15.3

307.7

2955

1597

207

Kela drug reimbursment

Chronic arrhythmias

100.8

307.7

4585

456

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

10.9

307.7

473

294

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

3.5

307.7

1591

3236

160

Kela drug reimbursment

exenatide

53.8

307.7

407

L28

ICPC

Limited function/disability (L)

3.5

307.7

2581

5570

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

10.6

307.7

4557

4099

FL1AC

NOMESCO Finland

Left cardioangiography

25.3

307.7

317

N05CF01

ATC

zopiclone; oral

2.2

307.7

4202

14949

250, ,

Kela drug reimbursment

915.3

307.7

912

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

168.5

307.7

1383

C07AG02

ATC

carvedilol; oral

105.4

307.7

1107

201

Kela drug reimbursment

Chronic cardiac insufficiency

49.9

307.7

3459

612

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

6.4

307.7

1781

2052

ZXE00

NOMESCO Finland

One hour or less

2.3

307.7

5125

18656

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

56.5

307.7

1116

141

I49.5

ICD-10 Finland

Sick sinus syndrome

16.0

307.7

662

284

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

109.1

307.7

725

C09AA03

ATC

lisinopril; oral

76.9

307.7

509

A46

ICD-10 Finland

Erysipelas

4.9

307.7

2884

4690

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

22.4

307.7

531

161

A10BJ06

ATC

semaglutide; parenteral

17.0

307.7

831

340

SPAT1249

SPAT

Treatment-related counselling outside office

2.2

307.7

4443

16412

R55

ICD-10 Finland

Syncope and collapse

3.2

306.9

1473

3219

N17.8

ICD-10 Finland

Other acute renal failure

19.1

306.3

323

113

N02AJ06

ATC

codeine and paracetamol; systemic

2.1

304.8

5059

20016

SPAT1229

SPAT

Assessment of need for aid

3.8

303.3

1120

2045

I34.1

ICD-10 Finland

Mitral (valve) prolapse

8.4

303.2

497

402

A10BB01

ATC

glibenclamide; oral

6.4

301.8

613

649

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.1

300.8

4060

14821

K80

ICPC

Cardiac arrhythmia NOS

4.5

299.3

894

1380

TFC25

NOMESCO Finland

Transseptal catheterisation of left atrium or ventricle

35.8

298.4

263

TK810

NOMESCO Finland

Hemofiltration

55.8

298.2

243

S18

ICPC

Laceration/cut

2.0

297.6

5633

23332

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

6.9

297.5

571

566

FPG30

NOMESCO Finland

Implantation of cardioverter-defibrillator with ventricular electrode

+∞

297.3

337

A10BJ05

ATC

dulaglutide; parenteral

20.1

296.5

307

102

NHQ40

NOMESCO Finland

Amputation of toe

13.0

296.3

370

191

SPAT1255

SPAT

Intravenous administration of medicine

4.0

295.6

1025

1784

R50.9

ICD-10 Finland

Fever, unspecified

2.7

295.3

2083

5670

FMD10

NOMESCO Finland

Replacement of aortic valve using biological prosthesis

36.6

294.1

258

SPAT1100

SPAT

Long-term monitoring of blood pressure

5.1

294.0

758

1026

K29

ICPC

Cardiovascular sympt/complt other

6.2

293.9

615

673

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

9.3

292.5

444

321

FPG32

NOMESCO Finland

Implantation of cardioverter-defibrillator with atrial and ventricular electrodes

383.0

290.6

343

TFP46

NOMESCO Finland

Ablation treatment of atrial fibrillation

29.2

288.8

267

A10BX07

ATC

[U] liraglutide

52.4

286.9

236

SPAT1216

SPAT

Assessment of functional ability

2.7

283.8

1893

4996

T89

ICPC

Diabetes insulin dependent

6.5

282.8

567

591

R60.9

ICD-10 Finland

Oedema, unspecified

4.6

282.6

808

1200

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

6.0

280.6

603

679

H3603, E103,

ICD-10 Finland

39.3

279.9

242

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

4.1

279.7

929

1562

A10AD05

ATC

insulin aspart; parenteral

18.3

279.1

299

109

J96.0

ICD-10 Finland

Acute respiratory failure

13.4

278.6

343

172

C02DE04, ,

ATC

25.9

276.4

264

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

7.5

275.4

491

444

I47.1

ICD-10 Finland

Supraventricular tachycardia

6.9

274.7

524

515

A06AD11

ATC

lactulose; oral

2.6

274.4

2061

5776

I49.0

ICD-10 Finland

Ventricular fibrillation and flutter

28.3

273.6

255

GD1AD

NOMESCO Finland

Thorax CT examination

3.9

273.1

981

1751

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.4

273.1

2550

7924

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

1074.2

272.3

314

I42.8

ICD-10 Finland

Other cardiomyopathies

71.5

272.2

215

I42.2

ICD-10 Finland

Other hypertrophic cardiomyopathy

29.7

271.7

250

ZXD10

NOMESCO Finland

Scheduled procedure

2.0

270.5

4775

19117

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

3.5

270.3

1112

2188

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.7

270.2

1884

5081

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

28.3

269.4

251

Catheterization and pressure measurement of the left side of the heart

33.4

269.4

241

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

20.7

269.3

276

FPE30

NOMESCO Finland

Replacement of transvenous cardiac pacemaker pulse generator

26.6

268.9

255

N03AX16

ATC

[U] pregabalin

2.3

268.6

2862

9416

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

5.1

267.7

676

896

A04

ICPC

Weakness/tiredness general

2.8

267.5

1632

4096

AN2

Balloon angioplasty, including several vessels

9.6

267.4

398

279

SPAT1252

SPAT

Overall medication plan or its review

4.2

267.3

853

1388

Z50.0

ICD-10 Finland

Cardiac rehabilitation

91.2

267.3

206

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

4.5

267.3

786

1195

FN2AB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), drug-eluting balloon

22.7

266.5

265

SPAT1310

SPAT

Counselling related to known health issue

2.1

266.2

3437

12227

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

9.2

265.4

405

295

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

236.3

264.8

319

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

7.5

264.0

469

422

I21.90

ICD-10 Finland

Myocardial infarction (acute) UNS no detected stenosis of the coronary artery

16.8

263.4

292

116

UJF32

NOMESCO Finland

Coloscopy

2.1

262.6

3317

11689

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.5

261.9

2115

6131

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

4.5

261.7

771

1174

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

4.0

260.9

883

1505

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.9

260.1

5409

22844

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

5.7

259.6

587

697

K83

ICPC

Heart valve disease NOS

32.2

257.0

232

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

17.2

255.9

281

109

A10BD07

ATC

metformin and sitagliptin; systemic

6.4

255.4

516

542

C10AA07

ATC

rosuvastatin; oral

2.1

255.1

3411

12270

E86

ICD-10 Finland

Volume depletion

8.0

255.0

432

365

ZXE30

NOMESCO Finland

More than five and less than seven hours

4.2

254.0

804

1299

4019X

ICD-9 Finland

Essential hypertension, Unspecified

9.7

253.3

373

257

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

8.8

253.0

399

305

R00.1

ICD-10 Finland

Bradycardia, unspecified

7.0

252.5

476

461

TFP00

NOMESCO Finland

Temporary use of transvenous or epicardial pacemaker

28.4

252.5

235

FMD00

NOMESCO Finland

Replacement of aortic valve using mechanical prosthesis

41.0

251.9

216

H36.01

ICD-10 Finland

Diabetic maculopathy

21.7

251.9

254

A10AE06

ATC

insulin degludec; parenteral

7.1

249.5

464

442

L17

ICPC

Foot/toe symptom/complaint

2.1

248.7

3294

11788

JN4AD

NOMESCO Finland

Body CT examination

2.8

248.4

1554

3946

N05BA04

ATC

oxazepam; oral

2.2

248.3

2951

10118

162

Kela drug reimbursment

liraglutide

48.6

246.3

205

C07FB02

ATC

metoprolol and felodipine; systemic

480.7

245.6

288

B01AF03

ATC

edoxaban; oral

12.6

245.0

310

164

Z2446

NOMESCO Finland

Social worker

3.7

244.7

934

1740

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

6.3

243.9

504

543

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.7

243.1

1633

4305

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.9

242.7

1430

3510

J01MA14

ATC

moxifloxacin; systemic

3.0

242.0

1334

3152

H3600, E113,

ICD-10 Finland

30.0

240.7

221

J01MA02

ATC

ciprofloxacin; systemic

1.9

240.5

4843

20091

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

3.6

239.9

953

1826

I21.11

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

32.8

235.9

212

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

3.4

235.9

1026

2091

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

6.0

235.3

505

567

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

39.6

235.2

203

TFP44

NOMESCO Finland

Ablation treatment of typical atrial flutter

31.3

233.4

212

FN1BB

NOMESCO Finland

Contrast angiography of heart and/or coronary arteries after bypass surgery

59.4

232.6

188

A10AA01, ,

ATC

7.6

232.5

408

361

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.9

232.5

4900

20579

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

41.3

232.4

199

WX882

NOMESCO Finland

High dependency care

6.1

232.3

494

549

PE1AT

NOMESCO Finland

Femoral artery PTA

24.5

232.0

225

K92.1

ICD-10 Finland

Melaena

4.1

231.9

764

1273

TQW11

NOMESCO Finland

Vacuum treatment of wound

7.4

231.7

416

379

FPG96

NOMESCO Finland

Other implantation of permanent cardioverter-defibrillator

1724.3

231.1

265

FP4B5

NOMESCO Finland

ECG, prolonged recording (24 h)

13.8

230.5

279

135

R42

ICD-10 Finland

Dizziness and giddiness

2.2

230.0

2498

8224

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

3.7

229.8

861

1581

EBA15

NOMESCO Finland

Extraction of multiple teeth

4.3

229.2

704

1108

FKB10

NOMESCO Finland

Annuloplasty of mitral valve for insufficiency using ring

35.3

228.5

202

H3603, E113,

ICD-10 Finland

45.5

228.2

192

3AC01, ,

NOMESCO Finland

18.2

227.6

244

A10BH02

ATC

vildagliptin; oral

13.8

227.2

275

133

SPAT1325

SPAT

Vaccination

2.0

226.6

3548

13438

I48.3

ICD-10 Finland

Typical atrial flutter

21.2

226.6

230

N06AX11

ATC

mirtazapine; oral

2.0

226.3

3778

14636

FPE96

NOMESCO Finland

Other implantation or replacement of transvenous cardiac pacemaker

113.3

225.8

171

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

15.6

224.5

257

110

SPAT1104

SPAT

Monitoring of emergency patient

3.8

223.5

831

1517

A10BG03

ATC

pioglitazone; oral

10.2

223.0

318

208

I42.1

ICD-10 Finland

Obstructive hypertrophic cardiomyopathy

87.7

222.4

172

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

4.6

222.1

637

946

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

9.8

221.4

324

221

FPE37

NOMESCO Finland

Implantation of biventricular cardioverter-defibrillator with atrial and ventricular electrodes

+∞

221.1

251

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.9

219.9

1253

3011

C07AA05

ATC

propranolol; systemic

2.7

219.0

1496

3967

Z01.8

ICD-10 Finland

Other specified special examinations

2.1

218.7

2683

9258

177

Kela drug reimbursment

Insulin glargine 300 U / ml

12.0

216.9

282

157

K28

ICPC

Limited function/disability (K)

9.1

216.1

332

244

H36.00

ICD-10 Finland

Diabetic background retinopathy

15.8

215.7

245

103

R11

ICD-10 Finland

Nausea and vomiting

3.2

215.6

1040

2262

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

22.1

215.6

216

PD5BD

NOMESCO Finland

Extensive CT of aorta

12.0

214.8

279

155

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

243.7

213.6

257

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

7.2

213.5

392

367

SPAT1260

SPAT

Consultation of another employee

2.3

212.9

1979

6076

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

25.6

212.9

204

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

44.2

212.8

180

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

4.6

212.8

602

883

OAB50, ,

SPAT

4.2

211.6

670

1080

T82

ICPC

Obesity

6.0

210.1

448

499

AS4

Physiological pacemaker insertion DDD (R)

20.3

207.6

214

A10BX04

ATC

[U] exenatide

47.8

207.3

173

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

2.9

206.7

1152

2730

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

325.6

206.2

245

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.5

205.8

1611

4564

N05CD07

ATC

temazepam; oral

2.5

205.4

1634

4665

KA1AE

NOMESCO Finland

Kidney ultrasound examination

6.6

205.1

406

416

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

16.4

204.6

229

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

3.3

204.0

917

1905

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

4.1

202.9

657

1078

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

3.6

201.7

804

1540

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

5.1

201.3

506

666

I25.8

ICD-10 Finland

Other forms of chronic ischaemic heart disease

26.8

201.0

190

3025

Kela drug reimbursment

Calcium carbonate

101.2

200.3

153

PD5AD

NOMESCO Finland

CT of aorta

8.1

200.2

334

276

N18.4

ICD-10 Finland

Chronic kidney disease, stage 4

92.6

200.1

154

I44.1

ICD-10 Finland

Atrioventricular block, second degree

8.8

199.5

314

239

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

5.9

199.0

434

495

N05BA01

ATC

diazepam; systemic, rectal

2.5

198.8

1593

4560

SPAT1211

SPAT

Application of soft bandage

2.9

198.5

1091

2563

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

6.5

198.4

398

414

1CX08, ,

NOMESCO Finland

388.7

198.2

234

SPAT1081

SPAT

Cardiorespiratory global assessment

4.6

197.8

569

846

FN2CA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), treating more than one main trunk during a single procedure

24.8

197.7

191

I12.0

ICD-10 Finland

Hypertensive renal disease with renal failure

99.9

197.4

151

C09BA03

ATC

lisinopril and diuretics; oral

387.0

197.3

233

WX002

NOMESCO Finland

Sedation and analgesia

2.1

197.2

2369

8072

A02BC01

ATC

omeprazole; systemic

2.0

196.2

3141

11895

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

3.4

196.1

844

1703

C08CA10

ATC

nilvadipine; oral

754.8

195.6

227

N03AX12

ATC

[U] gabapentin; oral

2.3

193.8

1811

5557

J01DA01

ATC

[U] cefalexin

1.7

192.9

7381

36425

Z49.2

ICD-10 Finland

Other dialysis

498.4

192.0

225

T92

ICPC

Gout

9.9

192.0

279

188

I20.91

ICD-10 Finland

Angina pectoris, unspecified

43.2

191.9

163

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

15.7

191.6

218

WZC30

NOMESCO Finland

Teaching

2.2

191.0

2042

6632

SPAT1251

SPAT

Organisation of medication

5.3

190.7

465

594

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

5.6

190.6

437

525

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.9

190.3

3139

11992

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

3.0

190.1

1002

2295

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

11.5

188.0

250

145

E66.0

ICD-10 Finland

Obesity due to excess calories

19.4

187.2

196

WX730

NOMESCO Finland

Conventional respirator

7.7

185.8

323

282

N05AH04

ATC

quetiapine; oral

2.2

185.1

1862

5890

H05BX01

ATC

cinacalcet; oral

43.3

184.9

157

FME20

NOMESCO Finland

Transvenous aortic valve replacement via femoral artery

22.1

182.6

183

C02DE02, ,

ATC

24.4

182.4

177

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.7

182.2

1158

2944

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

9.5

181.8

271

190

ZXA00

NOMESCO Finland

Right side

1.9

181.8

3225

12596

TPX10

NOMESCO Finland

Implantation of vascular injection port

4.3

181.7

553

862

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

17.0

181.6

200

B05DA

ATC

Isotonic solutions

471.3

181.5

213

TFP30

NOMESCO Finland

Cathetric examination for cardiac arrythmia

26.5

181.4

172

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

207.7

181.4

220

280

Kela drug reimbursment

Clopidogrel

164.8

181.2

223

ZXE40

NOMESCO Finland

More than seven and less than nine hours

5.7

181.2

408

481

I21.19

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

16.7

181.0

201

I21.00

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

14.3

180.9

215

100

FWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels

41.0

180.8

155

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

84.1

180.2

140

FM1CG

NOMESCO Finland

Extensive examination of hear with high intensity magnet

27.8

179.6

168

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.7

179.4

5990

28229

H02AB04

ATC

methylprednisolone; systemic

2.2

178.9

1812

5742

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

6.9

178.2

338

329

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.1

178.0

899

2005

J01CF05

ATC

flucloxacillin; systemic

3.3

178.0

796

1645

K08.3

ICD-10 Finland

Retained dental root

2.8

177.9

1047

2552

E66

ICD-10 Finland

Obesity

4.5

176.7

519

785

C07AB04

ATC

acebutolol; systemic

38.9

176.7

153

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.4

176.7

1471

4274

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

457.8

176.2

207

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

10.1

174.9

250

164

A10AD01

ATC

insulin (human); parenteral

9.4

174.9

263

187

N18.3

ICD-10 Finland

Chronic kidney disease, stage 3

26.6

174.3

165

S76

ICPC

Skin infection other

3.4

174.3

736

1464

I21.97

ICD-10 Finland

Suspected acute myocardial infarction

16.8

173.3

192

WX725

NOMESCO Finland

Noninvasive ventilation

3.3

172.9

764

1566

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.7

172.1

4609

20353

Z95.8

ICD-10 Finland

Presence of other cardiac and vascular implants and grafts

80.5

171.8

134

A10BJ01

ATC

exenatide; parenteral

27.9

171.1

160

I20.80

ICD-10 Finland

Other angina pectoris no detected stenosis of coronary artery

21.2

170.5

173

TFP47

NOMESCO Finland

Ablation or modification of the AV-node

656.8

170.1

198

B05DB

ATC

Hypertonic solutions

442.0

170.1

200

I34.9

ICD-10 Finland

Nonrheumatic mitral valve disorder, unspecified

29.5

169.3

156

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

19.0

168.8

178

K90

ICPC

Stroke/cerebrovascular accident

6.2

168.5

349

376

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.8

168.3

607

1080

AQ1

Conventional electrophysiological examination

19.4

168.2

176

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

435.3

167.5

197

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.9

167.1

936

2216

R31

ICD-10 Finland

Unspecified haematuria

2.5

166.8

1251

3454

A10BD03

ATC

metformin and rosiglitazone; systemic

15.7

165.8

189

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.0

165.5

2360

8517

N06AB04

ATC

citalopram; systemic

2.0

165.5

2316

8302

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

4.6

165.5

464

674

L04AD01

ATC

ciclosporin; systemic

7.0

163.9

304

288

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

217.8

163.7

198

OAB43, ,

SPAT

0.4

163.5

780

12618

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

27.3

162.8

153

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

5.3

162.1

389

489

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

3.0

161.9

838

1894

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.8

161.6

970

2386

4130B

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),AHTAUTUNUT]

17.6

161.0

175

B01AC07

ATC

dipyridamole; systemic

4.1

160.9

524

862

J46

ICD-10 Finland

Status asthmaticus

5.0

160.7

409

544

XF409

NOMESCO Finland

Other special ECG

34.8

160.2

142

C02EA03, ,

ATC

54.1

160.0

131

V03AE02

ATC

sevelamer; oral

253.7

159.9

192

Z02.7

ICD-10 Finland

Issue of medical certificate

3.0

159.9

841

1919

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.6

159.7

625

1179

R33

ICD-10 Finland

Retention of urine

2.7

159.3

1037

2664

321

Kela drug reimbursment

Paricalcitol and cinacalcet

30.9

159.2

145

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.8

158.7

3157

12705

J45.1

ICD-10 Finland

Nonallergic asthma

2.9

158.5

869

2031

J01FA06

ATC

roxithromycin; oral

1.7

158.4

4550

20371

I34.0

ICD-10 Finland

Mitral (valve) insufficiency

9.8

158.1

231

157

C09BA05

ATC

ramipril and diuretics; oral

183.5

157.9

193

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

6.2

157.3

324

347

GD2SN

NOMESCO Finland

Lung ventilation SPECT

18.4

156.6

167

Z96.1

ICD-10 Finland

Presence of intraocular lens

2.2

156.3

1563

4908

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

11.0

156.2

213

129

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

3.0

156.2

810

1832

I48.4

ICD-10 Finland

Atypical atrial flutter

68.2

156.1

124

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

9.4

155.8

234

166

WX740

NOMESCO Finland

Nitrogen oxide therapy

50.1

155.7

129

NGQ20

NOMESCO Finland

Amputation of lower leg

22.3

155.3

155

J01CA04

ATC

amoxicillin; systemic

1.7

155.1

9429

51277

U14

ICPC

Kidney symptom/complaint

9.4

154.8

232

164

L89

ICD-10 Finland

Decubitus ulcer and pressure area

6.1

153.9

323

353

ZXD00

NOMESCO Finland

Emergency procedure

4.9

153.8

407

561

I95.9

ICD-10 Finland

Hypotension, unspecified

8.7

153.7

243

186

C02LM02, ,

ATC

79.2

153.5

120

H36.09*E11.3

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic retinopathy

32.6

153.4

138

AP2

Catheterization of the right side of the heart

62.4

153.2

123

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

3.3

153.0

672

1370

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

13.5

152.7

186

M48.0

ICD-10 Finland

Spinal stenosis

2.4

152.3

1319

3889

ZXA05

NOMESCO Finland

Left side

1.8

152.2

2948

11742

K05

ICPC

Irregular heartbeat other

6.1

152.1

321

353

XPX08

NOMESCO Finland

Intraoperative flow measurement

20.9

152.1

155

R07.3

ICD-10 Finland

Other chest pain

2.5

151.8

1134

3120

WX213

NOMESCO Finland

Lower leg blockade

13.9

151.1

182

N18

ICD-10 Finland

Chronic kidney disease

22.5

150.8

150

PE1YT

NOMESCO Finland

Femoral or popliteal artery PTA with stent

22.5

150.8

150

FN1BE

NOMESCO Finland

Ultrasound examination of coronary arteries through catheter

66.0

150.5

120

A11

ICPC

Chest pain NOS

2.9

149.3

840

1991

R95

ICPC

Chron obstructive pulmonary disease

4.5

148.5

429

639

Z94.1

ICD-10 Finland

Heart transplant status

199.9

148.0

180

H3601, E103,

ICD-10 Finland

19.3

148.0

155

A41.8

ICD-10 Finland

Other specified sepsis

5.9

147.6

322

367

C08CA07

ATC

nisoldipine; oral

60.4

147.5

119

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

7.6

147.4

258

227

C02CA01

ATC

prazosin; oral

8.5

147.3

237

186

40199

ICD-8 Finland

Essential benign hypertension

9.5

147.2

219

153

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

3.8

146.5

530

944

A10BG02

ATC

rosiglitazone; oral

12.7

146.3

184

EBA00

NOMESCO Finland

Extraction of tooth

1.7

146.2

3891

16976

3A064, ,

NOMESCO Finland

59.9

146.1

118

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

41.3

146.0

125

M79.6

ICD-10 Finland

Pain in limb

1.7

145.3

4426

20018

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.4

145.3

1242

3637

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.0

145.1

1942

6820

H02AB07

ATC

prednisone; oral

2.1

144.8

1698

5674

I21.4

ICD-10 Finland

Acute subendocardial myocardial infarction

11.0

144.2

196

118

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

10.1

144.2

206

135

SPAT1070

SPAT

Doppler ultrasound examination of blood flow in arteries of lower extremity

8.0

143.4

241

201

UKC02

NOMESCO Finland

Cystoscopy

2.0

143.1

1851

6417

212

Kela drug reimbursment

Gout

6.3

142.8

292

310

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

3.4

142.2

608

1217

AS2

Ventricular pacemaker insertion VVI (R)

40.3

141.8

122

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

5.0

141.6

365

491

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

5.6

141.5

321

381

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

6.5

141.3

281

289

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.0

140.5

2016

7251

SPAT1281

SPAT

Other administrative function

2.8

140.4

835

2040

R5110, ,

SPAT

2.9

140.1

771

1803

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

4.0

139.8

470

792

A10BX01

ATC

guar gum; oral

4.5

139.6

402

597

C09DX01

ATC

valsartan, amlodipine and hydrochlorothiazide; oral

273.8

138.7

166

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

11.5

138.4

183

105

N06AA09

ATC

amitriptyline; systemic

2.5

137.5

1051

2919

SPAT1234

SPAT

Support of social functional capacity

3.4

137.2

593

1195

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

29.7

137.0

126

196

Kela drug reimbursment

Paricalcitol and cinacalcet

356.7

136.8

162

K04

ICPC

Palpitations/awareness of heart

3.8

135.9

486

858

C02EA01, ,

ATC

16.8

135.7

150

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

4.1

135.6

438

715

WX402

NOMESCO Finland

General anaesthesia

1.9

135.6

2416

9331

WZC00

NOMESCO Finland

Treatment plan or consultation

1.7

135.2

4064

18237

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

182.7

135.0

165

CJB10

NOMESCO Finland

Laser discission of secondary cataract

2.6

134.8

910

2376

PE1BT

NOMESCO Finland

Femoral artery extensive PTA

25.0

134.0

129

J01AA02

ATC

doxycycline; systemic

1.7

133.9

9299

51155

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

123.6

133.8

168

B82

ICPC

Anaemia other/unspecified

5.2

133.7

328

421

PAF14

NOMESCO Finland

Thrombendarterectomy of internal carotid artery

13.8

133.6

161

J81

ICD-10 Finland

Pulmonary oedema

18.2

133.4

143

N30.0

ICD-10 Finland

Acute cystitis

2.1

133.4

1566

5225

ZZA00

NOMESCO Finland

Split skin graft

4.1

133.0

424

685

B03XA01

ATC

erythropoietin; parenteral

12.4

133.0

169

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.9

132.9

731

1708

I95.1

ICD-10 Finland

Orthostatic hypotension

4.1

132.6

430

704

ZX108

NOMESCO Finland

Inhalation

10.3

132.5

187

120

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

16.9

132.5

146

G04CA02

ATC

tamsulosin; oral

1.8

132.0

2755

11158

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

2.5

131.8

977

2672

WW500

NOMESCO Finland

Blood transfusion

3.2

130.9

598

1249

FM1JR

NOMESCO Finland

Heart, extensive metabolic PET with CT

62.9

130.8

105

GD1UN

NOMESCO Finland

Lung circulation SPECT

19.3

130.6

137

E0000UV, ,

ATC

1.6

130.2

4468

20691

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

1008.8

129.8

150

Z95.3

ICD-10 Finland

Presence of xenogenic heart valve

62.3

129.4

104

C07AA03

ATC

pindolol; systemic

17.1

129.3

142

H25.8

ICD-10 Finland

Other senile cataract

2.3

129.1

1155

3444

I34.01

ICD-10 Finland

Mitral (valve) regurgitation NOS or of specified cause, except rheumatic

23.3

129.1

127

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

5.4

128.6

304

376

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

4.0

128.4

431

725

H26.4

ICD-10 Finland

After-cataract

2.4

128.4

1061

3053

XG410

NOMESCO Finland

Flow-volume spirometry

3.4

128.3

531

1039

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.7

128.2

816

2065

A29

ICPC

General symptom/complaint other

2.2

127.8

1366

4388

A08AB01

ATC

orlistat; oral

23.1

127.7

126

C09BA04

ATC

perindopril and diuretics; systemic

149.4

127.6

158

A01

ICPC

Pain general/multiple sites

2.5

127.6

960

2643

Z71.8

ICD-10 Finland

Other specified counselling

1.7

127.5

3120

13209

CKC15

NOMESCO Finland

Panretinal photocoagulation

15.2

127.4

147

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.8

127.3

747

1809

H43.1

ICD-10 Finland

Vitreous haemorrhage

4.6

127.3

357

518

ZXA10

NOMESCO Finland

Bilateral

1.9

127.3

2018

7488

WX110

NOMESCO Finland

Infiltration anesthesia

1.6

127.0

7949

42330

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.4

126.6

1044

3000

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.8

126.6

745

1807

J01CE08

ATC

benzathine benzylpenicillin; parenteral

9.0

126.4

195

144

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.6

126.4

487

907

C10AA02

ATC

lovastatin; oral

4.4

126.2

369

555

WW200

NOMESCO Finland

Immunization

4.1

125.4

404

658

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

4.5

124.9

364

546

R04.2

ICD-10 Finland

Haemoptysis

3.6

124.6

476

881

PD4CC

NOMESCO Finland

Very extensive arterigography of lower extremity with X-ray

23.0

123.5

122

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.6

123.3

864

2296

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

5.7

123.1

277

326

342

Kela drug reimbursment

Dronedarone

475.4

122.7

144

J96.9

ICD-10 Finland

Respiratory failure, unspecified

11.7

122.7

161

PEN23

NOMESCO Finland

Plastic repair of femoral artery

20.0

122.7

127

J94.8

ICD-10 Finland

Other specified pleural conditions

5.5

122.7

286

349

B01AB04

ATC

dalteparin; parenteral

2.9

122.6

658

1515

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

20.3

122.4

126

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.5

122.0

888

2404

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.9

122.0

689

1633

A10AB06

ATC

insulin glulisine; parenteral

12.9

121.9

152

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

11.8

121.8

159

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

6.2

121.2

250

268

XF602

NOMESCO Finland

Bloodpressure monitoring

10.7

121.2

167

103

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

4.6

121.1

339

491

I95.2

ICD-10 Finland

Hypotension due to drugs

38.4

120.9

105

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

2.2

120.9

1280

4092

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

4.3

120.7

363

559

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

13.2

120.2

148

B80

ICPC

Iron deficiency anaemia

5.6

118.6

271

324

S20

ICPC

Corn/callosity

5.2

118.4

289

369

5253

FHL

Cardiac lung machine

18.5

118.4

126

R06.2

ICD-10 Finland

Wheezing

3.3

118.2

527

1083

SPAT1312

SPAT

General health counselling

1.7

117.1

3081

13255

XF622

NOMESCO Finland

Measurement of minute volume of heart

25.5

116.9

112

R4190

NOMESCO Finland

Nutritional therapy

3.2

116.8

527

1091

C02DE10, ,

ATC

41.2

116.7

100

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

3.2

116.3

526

1091

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

3.9

116.1

399

683

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.8

116.1

664

1584

A07AA09

ATC

vancomycin; oral

6.2

115.9

239

256

315

Kela drug reimbursment

Clopidogrel

16.2

115.9

130

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

6.0

115.8

245

270

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.2

115.7

1197

3788

FN2CB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of coronary chronic total occlusion

33.9

115.6

103

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

4.4

115.2

341

518

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

14.6

115.1

135

FN2AA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), balloon only

27.4

115.0

108

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.8

114.8

2001

7634

R4180

NOMESCO Finland

Podiatric therapy

7.6

114.8

199

173

TFJ02

NOMESCO Finland

Muscle biopsy of heart

185.7

114.7

140

FPE40

NOMESCO Finland

Replacement of transvenous cardiac pacemaker electrode

29.1

114.7

106

SPAT1153

SPAT

Removal of sutures

1.6

113.9

3376

14964

N02BF02

ATC

pregabalin; oral

2.8

113.4

645

1534

I21.10

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

18.4

112.6

120

SPAT1151

SPAT

Treatment of major wounds

7.2

112.4

205

190

V03AE03

ATC

lanthanum carbonate; oral

294.1

112.4

134

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

8.1

112.3

186

152

4120B

ICD-9 Finland

Old myocardial infarction[STATUS POST INFARCTUM CORDIS,AHTAUTUNUT]

15.1

112.3

130

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

3.5

112.2

449

858

K74

ICPC

Ischaemic heart dis with angina

16.7

112.0

124

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.2

111.7

1179

3760

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

6.2

111.6

229

244

R96

ICPC

Asthma

2.3

111.4

964

2826

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.6

111.3

3612

16357

AB2

AVR bio, stent

50.5

111.1

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

3.8

110.6

395

696

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.1

110.3

1293

4295

FQA10

NOMESCO Finland

Orthotopic transplantation of heart with bicaval anastomosis

+∞

109.9

125

ANC

Coronary artery pressure measurement (FFR, fractional flow reserve)

18.4

109.7

117

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

5.3

109.7

263

330

B01AB10

ATC

tinzaparin; parenteral

2.1

109.7

1175

3768

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

109.7

3683

16808

R05

ICPC

Cough

1.7

109.5

2369

9632

R05FB02

ATC

cough suppressants and expectorants; systemic

1.6

109.1

4122

19338

R18

ICD-10 Finland

Ascites

4.2

108.9

339

537

SPAT1101

SPAT

Orthostatic test

3.7

108.8

402

726

NF1AA

NOMESCO Finland

Hip X-ray examination

2.3

108.5

1001

3017

PG1XE

NOMESCO Finland

Other ultrasound examination of blood vessel not elsewhere classified

19.6

108.5

113

N06AX21

ATC

duloxetine; oral

2.2

108.4

1094

3424

4273A

ICD-9 Finland

Cardiac dysrhythmias, Atrial fibrillation and flutter

5.4

108.4

257

319

TGC00

NOMESCO Finland

Bronchial lavation

3.7

108.3

397

713

PD4AD

NOMESCO Finland

CT of lower extremity arteries

12.0

108.3

140

QDB10, ,

SPAT

5.6

108.3

245

290

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

3.1

107.6

533

1169

R03AK03

ATC

[U] fenoterol and ipratropium bromide

2.6

107.4

744

1963

FXG00

NOMESCO Finland

Insertion and use of IABP

52.7

107.0

FC1AC

NOMESCO Finland

Angiography of thoracal aortta

27.4

106.6

100

I34.2

ICD-10 Finland

Nonrheumatic mitral (valve) stenosis

27.4

106.6

100

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.2

105.7

1078

3387

I45.9

ICD-10 Finland

Conduction disorder, unspecified

11.7

105.2

138

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

4.8

105.0

281

391

FKC50

NOMESCO Finland

Repair of mitral valve for insufficiency using prosthetic chord

29.0

104.9

K22

ICPC

Risk factor cardiovascular disease

2.8

104.2

609

1469

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

3.7

104.1

385

696

SPAT1304

SPAT

Counselling and guidance related to ageing

2.6

103.8

690

1782

A02BC03

ATC

lansoprazole; oral

1.6

103.7

3000

13164

I35.9

ICD-10 Finland

Aortic valve disorder, unspecified

23.2

103.5

102

Z3229

NOMESCO Finland

Other healthcare associate professional

2.3

103.4

940

2813

FPH10

NOMESCO Finland

Open removal of transvenous cardiac pacemaker or cardioverter-defibrillator

107.3

102.4

130

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.2

102.2

961

2918

5315

FHL

Bypass surgery using a mammary artery

20.3

102.1

105

TK820

NOMESCO Finland

Peritoneal dialysis

395.2

101.7

120

R4180, ,

SPAT

10.6

101.6

141

C10AB02

ATC

bezafibrate; oral

11.0

101.6

138

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

7.1

101.2

185

172

E05.89

ICD-10 Finland

Other thyrotoxicosis

27.2

101.0

FNC40

NOMESCO Finland

Aorto-coronary venous bypass with four distal anastomoses

119.8

101.0

127

D64.8

ICD-10 Finland

Other specified anaemias

5.7

100.6

225

263

I44.0

ICD-10 Finland

Atrioventricular block, first degree

6.7

100.3

193

191

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.4

99.9

805

2282

C02DE01, ,

ATC

20.0

99.5

103

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.2

99.4

951

2907

L04AX01

ATC

azathioprine; systemic

2.9

99.3

534

1229

C01BD07

ATC

dronedarone; oral

385.2

99.1

117

K92

ICPC

Atherosclerosis/periph vascular dis

8.8

99.1

154

115

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

10.3

98.7

139

R03BA05

ATC

fluticasone; inhalant

1.8

98.6

1835

7115

CKC10

NOMESCO Finland

Local photocoagulation of retina

5.2

98.6

239

303

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

4.0

98.5

325

539

H03BB01

ATC

carbimazole; oral

3.3

98.4

437

895

WX100

NOMESCO Finland

Conjunctival surface anesthesia

2.0

98.3

1232

4187

R00.0

ICD-10 Finland

Tachycardia, unspecified

3.8

98.0

354

629

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

30.8

97.7

CKC12

NOMESCO Finland

Photocoagulation of retina

2.8

97.6

559

1333

I21.9

ICD-10 Finland

Acute myocardial infarction, unspecified

4.6

97.4

272

393

AQ2

Electrophysiological electroanatomical examination

52.6

97.2

XW000

NOMESCO Finland

Bone marrow biopsy

2.9

97.2

540

1266

288

Kela drug reimbursment

Febuxostat

45.0

97.2

L04AA01

ATC

[U] ciclosporin

5.6

97.1

218

256

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.7

96.8

2100

8513

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

254.0

96.7

116

I20.9

ICD-10 Finland

Angina pectoris, unspecified

10.0

96.7

139

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.9

96.6

1415

5079

C08CA03

ATC

isradipine; systemic

157.0

96.6

119

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

3.7

96.2

360

656

R4120

NOMESCO Finland

Occupational therapy

2.5

96.1

727

2000

FN2CC

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of left main trunk

24.5

96.0

I74.3

ICD-10 Finland

Embolism and thrombosis of arteries of lower extremities

7.5

95.9

169

150

E87.2

ICD-10 Finland

Acidosis

16.4

95.9

107

D07AC01

ATC

betamethasone; topical

1.5

95.8

3832

18095

SPAT1245

SPAT

Provision of support and information to patient’s family members

3.2

95.8

438

914

I20

ICD-10 Finland

Angina pectoris

9.6

95.7

141

R03AK07

ATC

formoterol and budesonide; inhalant

1.7

95.5

2130

8698

H03AA01

ATC

levothyroxine sodium; systemic

1.7

95.5

2295

9566

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

4.7

95.2

258

363

H3600, E103,

ICD-10 Finland

9.0

95.1

146

107

4100X

ICD-9 Finland

Acute myocardial infarction, Of anterolateral wall[INFARCTUS MYOCARDII ACUTUS DEFINITUS,MÄÄRITTELEMÄT]

5.5

95.1

219

264

E11.1

ICD-10 Finland

Type 2 diabetes mellitus, with ketoacidosis

13.4

95.0

116

WX720

NOMESCO Finland

Own respiration

2.9

94.8

515

1192

R06

ICPC

Nose bleed/epistaxis

4.8

94.6

250

344

NFQ20

NOMESCO Finland

Amputation of femur

10.3

94.5

133

I21.21

ICD-10 Finland

Acute transmural myocardial infarction with another location stenosed coronary artery

38.5

94.5

I31.9

ICD-10 Finland

Disease of pericardium, unspecified

10.7

94.5

130

Q23.11

ICD-10 Finland

Bicuspid aortic valve

9.8

94.5

137

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

3.0

93.8

489

1105

WW502

NOMESCO Finland

Autotransfusion

18.3

93.6

100

JN4BD

NOMESCO Finland

Extensive body CT

1.9

93.6

1321

4680

J45.8

ICD-10 Finland

Mixed asthma

3.5

93.4

366

689

SPAT1053

SPAT

Memory test

2.0

93.4

1275

4464

A02BA02

ATC

ranitidine; systemic

1.7

93.4

2040

8278

N05AX08

ATC

risperidone; systemic

2.2

93.3

904

2776

I21.39

ICD-10 Finland

Acute transmural myocardial infarction with unspecified localization unspecified coronary artery status

20.9

93.2

B03BA03

ATC

hydroxocobalamin; parenteral

2.6

92.9

612

1572

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

11.1

92.9

125

R60.1

ICD-10 Finland

Generalized oedema

11.1

92.9

125

I71.9

ICD-10 Finland

Aortic aneurysm of unspecified site, without mention of rupture

7.8

92.9

158

134

R03BA02

ATC

budesonide; inhalant

1.8

92.8

1811

7112

SPAT1231

SPAT

Assessment of adjustments needed in living environment

5.0

92.7

235

311

SPAT1139

SPAT

Nutrition survey

3.8

92.7

333

589

FPJ24

NOMESCO Finland

Revision of biventricular cardioverter-defibrillator with atrial and ventricular electrodes

+∞

92.3

105

W19

ICD-10 Finland

Unspecified fall

2.0

92.3

1108

3703

I41.8*D86.8

ICD-10 Finland

Sarcoid myocarditis

97.3

92.1

118

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.3

92.0

806

2371

FP1C5

NOMESCO Finland

Resting ECG, 15 leads

7.9

91.9

154

128

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

4.0

91.5

301

498

A99

ICPC

Disease/condition unspecnature/site

2.2

91.4

923

2883

B04AB02, ,

ATC

6.9

91.3

172

166

K65.0

ICD-10 Finland

Acute peritonitis

5.5

91.2

210

253

OAA67, ,

SPAT

0.4

91.0

382

6717

-50

ICPC

Medication/prescr/renewal

3.1

90.7

437

942

A02BC05

ATC

esomeprazole; systemic

1.5

90.6

4263

20789

N06AX16

ATC

venlafaxine; oral

1.9

90.5

1297

4615

AS7

Arrhythmia pacemaker insertion VVI (R) S

+∞

90.5

103

N05AA02

ATC

levomepromazine; systemic

2.8

90.4

525

1261

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.6

90.4

341

625

Z51.5

ICD-10 Finland

Palliative care

2.1

90.4

976

3131

L14

ICPC

Leg/thigh symptom/complaint

2.3

90.3

808

2398

TFP32

NOMESCO Finland

Cathetric treatmen of cardiac arrythmia

20.9

90.3

AP4

Myocardial biopsy

691.7

90.3

105

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

3.2

90.1

423

897

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.7

90.0

566

1419

SPAT1054

SPAT

Examination of peripheral nervous system

6.3

89.9

182

191

C09CA08

ATC

olmesartan medoxomil; oral

107.4

89.8

114

R41.0

ICD-10 Finland

Disorientation, unspecified

3.6

89.8

340

625

X59

ICD-10 Finland

Exposure to unspecified factor

1.7

89.5

2130

8838

J45

ICD-10 Finland

Asthma

2.1

89.5

986

3187

S10

ICPC

Boil/carbuncle

2.6

89.5

613

1606

PD3AT

NOMESCO Finland

Pelvic artery PTA

17.0

89.1

RS221, ,

NOMESCO Finland

5.2

88.9

215

272

I21.91

ICD-10 Finland

Myocardial infarction (acute) UNS stenosed coronary artery

41.6

88.9

M04AA03

ATC

febuxostat; oral

48.7

88.8

FXL00

NOMESCO Finland

Insertion and use of extra-, para- or intracorporeal VAD

678.4

88.6

103

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

7.0

88.5

163

153

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.9

88.2

1287

4607

Z95.4

ICD-10 Finland

Presence of other heart-valve replacement

38.4

87.5

G04BE03

ATC

sildenafil; oral

4.3

87.5

262

402

I63.1

ICD-10 Finland

Cerebral infarction due to embolism of precerebral arteries

8.0

87.3

145

119

K05.31

ICD-10 Finland

Periodontitis pronounced

1.9

86.7

1234

4379

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.9

86.5

1328

4832

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

3.6

86.5

332

616

N30.9

ICD-10 Finland

Cystitis, unspecified

2.5

86.4

628

1694

E78.29

ICD-10 Finland

Other mixed hyperlipidaemia

8.8

86.3

134

100

R03AC12

ATC

salmeterol; inhalant

2.7

86.2

545

1370

F05.9

ICD-10 Finland

Delirium, unspecified

4.2

86.1

265

416

I20.0

ICD-10 Finland

Unstable angina

14.6

85.4

100

SPAT1167

SPAT

Insertion of urinary catheter

3.4

85.1

349

678

SPAT1285

SPAT

Provision of consultation response

2.7

85.0

517

1273

M01AB01

ATC

indometacin; systemic, rectal

2.2

84.9

825

2534

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

6.1

84.8

176

190

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

4.3

84.7

254

390

R03AC13

ATC

formoterol; inhalant

2.6

84.5

558

1435

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.6

83.7

2575

11384

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

83.7

1354

5009

E000001, ,

ATC

1.7

83.6

1969

8133

G63.2

ICD-10 Finland

Diabetic polyneuropathy

23.5

83.6

N02BF01

ATC

gabapentin; oral

2.3

83.5

761

2275

R03BA01

ATC

beclometasone; inhalant

1.8

83.5

1412

5298

Electrophysiological Special Examination

14.9

83.4

U04

ICPC

Incontinence urine

2.7

83.3

506

1245

WX870

NOMESCO Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2749

8276

2.48

320.55

3.9

2.5

2.87

2.02

e6/l

4.07

1593

4343

(3010375) cycloSPORINE [Mass/volume] in Blood

296

29.10

319.76

29.7

23.5

116.89

147.60

ug/l

3.01

210

(3001122) Ferritin [Mass/volume] in Serum or Plasma

6964

19658

3.82

307.65

4.6

2.2

193.00

150.95

ug/l

4.52

6599

18116

(3043409) Potassium [Moles/volume] in Arterial blood

905

1018

6.17

307.65

7.1

3.6

4.00

3.82

mmol/l

14.29

896

1009

(3003434) Protein [Mass/volume] in Pleural fluid

640

485

9.02

307.65

1.6

1.3

27.50

38.42

g/l

49.40

556

452

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

9065

8572

20.34

307.65

6.4

1.7

2882.05

502.34

ng/l

161.04

8564

6860

(3001604) Monocytes [#/volume] in Blood

7739

27366

3.08

307.65

8.4

5.8

0.66

0.56

e9/l

135.62

6872

23593

(3019198) Lymphocytes [#/volume] in Blood

7838

28209

3.04

307.65

8.6

5.8

1.70

1.93

e9/l

14.90

7050

24835

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1055

1228

6.02

307.65

4.4

2.5

3.69

3.59

g/l

0.90

1019

1170

(3023520) Reticulocytes [#/volume] in Blood

2409

3259

5.70

307.65

3.1

3.0

76.70

66.28

e9/l

17.36

1885

2457

(3031040) Bacteria [#/volume] in Urine by Automated count

8671

35319

2.80

307.65

6.4

3.5

1224.91

1530.35

e6/l

0.22

156

500

(3009508) Creatinine [Moles/volume] in Urine

5492

8631

6.45

307.65

4.2

2.6

6.76

8.14

mmol/l

70.06

4667

7227

(3012516) Albumin [Mass/volume] in Urine

5377

7715

7.05

307.65

4.3

2.6

306.58

1058.55

mg/l

10.83

4015

3990

(3019060) Gas panel - Arterial blood

2159

2362

6.96

307.65

6.5

4.1

—

(3018418) pH of Serum or Plasma

5331

14907

3.26

307.65

7.7

3.3

7.40

1.62

1296

2703

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

983

1432

4.77

307.65

4.7

2.1

87.51

94.08

11.27

964

1372

(3027801) Oxygen [Partial pressure] in Arterial blood

3561

4409

6.89

307.65

12.2

6.2

10.69

13.75

kpa

137.69

3415

4205

(3021589) Normoblasts [#/volume] in Blood

6379

24977

2.31

307.65

18.1

8.2

0.00

e9/l

0.22

5319

20315

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1769

1565

8.39

307.65

7.5

3.1

24.03

24.64

mmol/l

7.11

1733

1535

(3017143) Hepatitis C virus Ab [Presence] in Serum

2055

5225

2.87

307.65

2.2

1.5

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

774

914

5.82

307.65

3.3

1.7

126.07

132.33

g/l

5.74

603

614

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

2689

2472

8.70

307.65

3.2

1.7

13.27

5.66

ug/l

13.52

2428

2050

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

5182

16574

2.73

307.65

3.7

2.4

70.16

67.20

u/l

0.07

4882

15215

(3019309) Folate [Moles/volume] in Red Blood Cells

3429

8370

3.28

307.65

2.0

1.6

1275.78

1140.26

nmol/l

10.60

2718

6126

(3018095) Leukocytes [#/volume] in Urine

5610

18359

2.75

307.65

5.5

3.0

105.23

97.93

e6/l

0.21

4460

12540

(3004119) Hemoglobin [Mass/volume] in Venous blood

1734

2028

6.29

307.65

6.3

2.5

122.42

131.37

g/l

29.84

1683

2000

(3003458) Phosphate [Moles/volume] in Serum or Plasma

3898

5044

6.78

307.65

11.7

3.8

1.12

1.00

mmol/l

77.09

3707

4647

(3021447) Carbon dioxide [Partial pressure] in Venous blood

2991

3155

7.74

307.65

7.2

2.8

5.98

5.83

kpa

7.24

2904

3069

(3010421) pH of Blood

947

986

6.69

307.65

7.3

2.7

7.42

2.54

845

912

(3002032) Base excess in Venous blood by calculation

2978

3141

7.74

307.65

7.3

2.8

2.07

2.25

mmol/l

1.13

2586

2694

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1373

1664

5.91

307.65

2.4

1.8

2.39

2.60

ug/l

0.09

1262

1478

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

10220

44887

3.25

307.65

13.2

7.1

87.13

78.55

u/l

47.24

9909

42114

(3027456) Digoxin [Moles/volume] in Serum or Plasma

1238

116.04

307.65

3.1

2.1

0.85

0.80

nmol/l

0.27

979

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

4078

12867

2.56

307.65

3.6

2.2

—

(1616796) Gas panel - Central venous blood

909

768

8.24

307.65

6.2

2.5

—

(3021901) Oxygen saturation in Capillary blood

831

619

9.31

307.65

4.0

2.3

—

(3000850) Epithelial cells [#/volume] in Urine

3919

10191

3.16

307.65

3.9

2.2

5.32

4.79

e6/l

1.72

3629

9052

(3013826) Glucose [Moles/volume] in Serum or Plasma

9317

29131

4.81

307.65

10.9

3.5

7.34

6.34

mmol/l

247.44

9057

27295

(3009261) Glucose [Presence] in Urine by Test strip

6303

26212

2.11

307.65

5.2

2.9

0.00

estimate

0.28

1420

4524

(3023183) Ammonium ion [Moles/volume] in Plasma

919

801

7.99

307.65

3.4

2.3

33.45

34.05

umol/l

0.16

848

724

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

979

1265

5.39

307.65

2.3

1.9

12.35

10.20

mg/l

3.57

919

1181

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

4334

6899

5.65

307.65

2.4

1.7

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

3232

9967

2.49

307.65

1.8

1.5

9377742.93

37416740.41

pmol/l

3.29

2730

8213

(3027315) Oxygen [Partial pressure] in Blood

863

854

7.00

307.65

7.3

2.8

8.18

8.76

kpa

11.17

846

831

(3033658) Prothrombin time (PT) actual/Normal

4526

13818

2.75

307.65

7.2

3.3

76.06

94.32

287.19

4433

13495

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1333

2570

3.66

307.65

3.6

3.0

4.19

4.50

pmol/l

16.79

1231

2254

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

3140

4603

5.56

307.65

2.3

1.6

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

9005

41460

2.35

307.65

4.8

3.5

15.39

14.60

pmol/l

124.38

8353

37261

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

3163

4600

5.61

307.65

2.2

1.6

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

825

1039

5.47

307.65

1.9

1.7

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

5461

13768

3.74

307.65

3.0

1.9

242.92

216.94

u/l

0.76

5198

12875

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1959

2630

5.55

307.65

6.6

2.2

141.27

62.94

ng/l

101.49

1728

2220

(3044889) 12 lead EKG panel

9006

38051

2.76

307.65

7.2

2.5

—

(3002030) Lymphocytes/100 leukocytes in Blood

7365

27005

2.80

307.65

9.1

6.0

22.79

29.20

307.65

7073

25304

(3026008) Bacteria identified in Urine by Culture

5072

13729

3.31

307.65

4.0

2.7

—

(3028626) Oxygen [Partial pressure] in Capillary blood

973

785

8.68

307.65

4.5

2.9

7.91

8.24

kpa

4.68

952

771

(3002173) Hemoglobin [Mass/volume] in Arterial blood

2864

3552

6.47

307.65

13.8

7.0

119.87

123.53

g/l

10.74

2815

3441

(3030467) Casts [#/volume] in Urine by Automated count

4811

14113

2.95

307.65

4.6

2.6

0.80

0.33

e6/l

15.94

3949

10328

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1839

3932

3.40

307.65

2.4

2.6

358.11

379.93

nmol/l

3.21

1704

3642

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

947

1102

5.98

307.65

1.4

1.3

—

(3035350) Ketones [Presence] in Urine by Test strip

6251

25744

2.13

307.65

5.2

2.9

0.00

estimate

0.43

1585

4780

(3034860) Kappa light chains.free [Mass/volume] in Serum

1044

1163

6.29

307.65

2.9

4.2

63.71

44.68

mg/l

1.92

817

957

(3044640) Blood type and Crossmatch panel - Blood

5152

17029

2.62

307.65

3.8

2.2

—

(3026250) Tacrolimus [Mass/volume] in Blood

380

53.29

307.65

40.2

27.7

7.48

7.71

ug/l

0.31

353

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1020

1124

6.35

307.65

2.9

4.1

2.58

3.80

ratio

0.32

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

862

1013

5.89

307.65

5.3

2.8

2.17

1.12

mg/l

123.20

803

935

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1863

2155

6.43

307.65

15.5

7.9

24.39

24.54

mmol/l

0.86

1807

2101

(3013707) Erythrocyte sedimentation rate by Westergren method

9060

42774

2.26

307.65

5.9

3.6

19.26

10.47

mm/h

302.40

8511

39246

(3022948) Iron [Moles/volume] in Serum or Plasma

5020

5749

8.65

307.65

4.1

1.7

11.68

14.42

umol/l

75.84

4809

5334

(3014111) Lactate [Moles/volume] in Serum or Plasma

2706

3496

6.12

307.65

13.3

5.9

1.43

1.30

mmol/l

5.34

2644

3398

(3028271) Lactate [Moles/volume] in Capillary blood

621

604

7.01

307.65

2.5

1.6

1.69

1.73

mmol/l

0.27

607

591

(3004588) Protein electrophoresis panel - Serum or Plasma

1766

3016

4.27

307.65

2.3

2.7

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1260

1590

5.63

307.65

6.4

2.8

50.43

48.14

1.78

1242

1577

(3004789) Transferrin [Mass/volume] in Serum or Plasma

4873

5248

9.09

307.65

4.1

1.7

2.30

2.31

g/l

0.28

4652

4823

(3026493) Urate [Moles/volume] in Serum or Plasma

4836

12228

3.52

307.65

4.1

2.1

3237.10

4465.88

umol/l

1.26

4259

10773

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2179

5019

3.21

307.65

5.2

2.9

—

(3016502) Oxygen saturation in Arterial blood

3259

3808

7.12

307.65

12.6

6.7

94.31

96.38

39.81

3162

3658

(40758558) Short blood count panel - Blood

4145

14249

2.32

307.65

9.2

7.5

—

(3000991) Gas panel - Venous blood

2768

3033

7.30

307.65

15.3

6.9

—

(40760892) CBC W Ordered Manual Differential panel - Blood

7369

25841

2.98

307.65

9.5

6.4

—

(3009343) pH of Capillary blood

2002

2409

6.24

307.65

6.1

2.9

7.41

7.43

7.66

374

278

(3023199) Leukocytes [#/volume] in Pleural fluid

553

466

8.06

307.65

1.6

1.4

3703.00

4433.23

e6/l

0.15

407

344

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2036

2434

6.30

307.65

6.1

2.9

5.28

5.19

kpa

3.16

1972

2292

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

10547

53282

2.53

307.65

8.9

3.7

44.45

37.63

mmol/mol

307.65

9958

48492

(3022313) Gas panel - Capillary blood

1318

1801

5.21

307.65

6.8

3.1

—

(3022217) INR in Platelet poor plasma by Coagulation assay

9225

21462

7.17

307.65

33.1

5.7

1.51

1.11

inr

195.87

2982

5921

(3036489) Thrombin time

1071

1648

4.54

307.65

4.3

2.0

22.52

20.97

7.46

998

1433

(3020630) Protein [Mass/volume] in Serum or Plasma

2341

3680

4.85

307.65

2.5

2.9

64.57

66.82

g/l

25.83

2191

3337

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

8314

25697

4.07

307.65

15.5

5.1

1.19

1.22

mmol/l

210.41

7200

21539

(3013650) Neutrophils [#/volume] in Blood by Automated count

8405

32590

2.93

307.65

12.3

9.7

4.81

3.77

e9/l

215.64

7531

28337

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

779

944

5.67

307.65

10.2

3.7

994.49

367.81

iu/ml

1.33

181

100

(3019069) Monocytes/100 leukocytes in Blood

7298

26196

2.86

307.65

9.3

6.2

8.95

8.68

9.96

7006

24477

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

6133

20062

2.88

307.65

2.4

1.7

91.64

96.88

pmol/l

13.01

3569

9772

(3042733) HLA Ab [Presence] in Serum

347

68.53

307.65

5.0

3.4

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1041

1159

6.30

307.65

3.0

4.2

61.36

29.06

mg/l

1.98

808

955

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1657

2454

4.91

307.65

2.0

1.6

—

(3020891) Body temperature

1172

1369

6.05

307.65

8.4

3.7

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

3818

6060

5.41

307.65

4.2

1.9

31.49

29.08

67.71

3730

5877

(3022096) Basophils/100 leukocytes in Blood

7125

25244

2.86

307.65

8.9

6.0

0.63

0.71

24.96

6834

23493

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1068

1573

4.75

307.65

7.2

4.2

1.84

1.67

3.43

1010

1461

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

5552

9853

5.67

307.65

3.0

1.9

3.35

2.84

mg/l

25.45

5000

8210

(3006504) Eosinophils/100 leukocytes in Blood

7277

26061

2.87

307.65

8.9

5.9

2.65

2.93

18.77

6975

24310

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

657

518

8.68

307.65

8.6

5.7

11.73

10.84

mg/l

3.67

611

476

(3007930) Methemoglobin/Hemoglobin.total in Blood

1038

1533

4.72

307.65

7.5

4.4

0.86

0.92

4.07

986

1422

(3021601) Nitrite [Presence] in Urine by Test strip

6227

25940

2.09

307.65

6.7

3.9

0.00

estimate

1.34

1514

4532

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

6652

25702

2.41

307.65

3.9

2.4

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1245

1873

4.70

307.65

1.3

1.5

9.26

10.73

u/ml

0.14

(40767503) Oxygen content in Capillary blood by calculation

833

785

7.34

307.65

4.0

2.0

15.48

16.78

9.55

505

385

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

4753

4812

9.58

307.65

4.2

1.7

20.55

25.10

49.25

4216

4110

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1995

3197

4.64

307.65

2.0

1.6

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2329

4847

3.61

307.65

2.5

2.2

0.19

0.22

g/l

30.05

2144

4538

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1320

1529

6.17

307.65

5.6

2.4

0.63

0.69

5.26

1311

1520

(3012544) pH of Venous blood

3069

3234

7.80

307.65

7.2

2.8

7.36

7.40

1.47

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1729

1387

9.24

307.65

1.9

1.7

1.58

1.50

g/l

1.43

1493

1167

(3015377) Calcium [Moles/volume] in Serum or Plasma

4894

18471

2.17

307.65

4.5

3.8

2.33

2.35

mmol/l

20.89

4331

16214

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

633

431

10.04

307.65

2.6

1.9

242.06

22.53

ug/min

12.11

410

215

(3037467) Urinalysis macro (dipstick) panel - Urine

8651

37300

2.53

307.65

6.4

3.5

—

(3013290) Carbon dioxide [Partial pressure] in Blood

836

852

6.79

307.65

7.3

2.8

5.09

5.03

kpa

0.86

819

829

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2012

2366

6.39

307.65

15.8

8.0

1.49

1.35

4.50

2000

2350

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

4557

7530

5.54

307.65

6.7

2.3

917.54

174.12

ng/l

3.77

4251

5171

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

7764

23370

3.89

307.65

14.0

4.6

1.19

1.22

mmol/l

182.74

7365

20982

(3012501) Base excess in Blood by calculation

835

852

6.78

307.65

7.3

2.8

2.94

2.51

mmol/l

2.62

613

607

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

3228

5182

5.08

307.65

5.9

5.3

266.61

245.80

u/l

5.65

3107

4916

(3013115) Eosinophils [#/volume] in Blood

7908

28431

3.08

307.65

8.9

6.0

0.19

e9/l

3.65

7062

24752

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

844

1072

5.43

307.65

1.8

1.6

—

(3014007) Fractional oxyhemoglobin in Arterial blood

2031

2373

6.44

307.65

16.1

8.1

92.48

94.57

23.58

2020

2368

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2906

8623

2.55

307.65

3.7

2.4

1.17

1.35

e6/l

0.21

1736

4664

(3042936) Bacteria identified in Isolate by Culture

3476

6894

4.13

307.65

3.0

1.7

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

7313

16690

5.24

307.65

6.8

2.2

102.44

24.94

ng/l

5.18

6236

10366

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1294

1363

6.78

307.65

3.8

1.9

606.45

426.69

ug/l

0.69

1249

1256

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

913

1282

4.93

307.65

4.9

2.4

224.42

182.71

25.38

883

1210

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1040

831

8.81

307.65

4.6

2.5

25.19

25.28

mmol/l

0.19

1019

819

(3018405) Lactate [Moles/volume] in Arterial blood

1107

1183

6.59

307.65

6.3

3.5

1.41

1.39

mmol/l

0.23

1085

1160

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1601

2441

4.75

307.65

1.8

1.4

—

(3026782) Osmolality of Urine

3709

9678

3.10

307.65

4.1

2.4

502.35

567.75

mosm/kgh2o

56.61

3324

8256

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1252

2101

4.20

307.65

2.2

1.9

35.16

42.55

u/l

19.69

983

1978

(3003396) Base excess in Arterial blood by calculation

3535

4418

6.80

307.65

12.2

6.1

1.36

1.15

mmol/l

1.58

2943

3552

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1071

1640

4.56

307.65

7.4

3.1

25.06

25.09

mmol/l

0.09

1021

1516

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1006

1351

5.19

307.65

2.2

1.5

—

(3002582) Erythrocytes [#/volume] in Urine

5213

15561

2.98

307.65

4.8

2.6

77.99

74.45

e6/l

0.08

4325

11602

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1722

986

13.00

307.65

4.8

2.6

0.33

0.35

u/ml

1.02

1104

507

(40760888) Immunoglobulin light chains.free panel - Serum

844

872

6.70

307.65

3.0

4.5

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

8619

28053

3.97

307.65

9.7

6.6

12.93

11.31

umol/l

20.35

8326

26634

(3024561) Albumin [Mass/volume] in Serum or Plasma

7452

22204

3.78

307.65

8.2

4.3

33.15

35.72

g/l

220.07

7088

20517

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

769

932

5.67

307.65

1.6

1.7

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2013

2360

6.41

307.65

16.1

8.0

0.63

0.68

4.23

2001

2345

(3020876) Protein [Mass/time] in 24 hour Urine

440

261

11.37

307.65

2.5

2.8

1.61

0.64

g/24h

4.27

265

108

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2315

5930

2.89

307.65

3.2

2.7

9.74

9.86

umol/l

0.08

2041

5220

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

3562

4412

6.88

307.65

12.2

6.2

5.21

5.16

kpa

1.33

3427

4200

(3027945) Reticulocytes/100 erythrocytes in Blood

3075

4443

5.61

307.65

3.1

2.7

2.04

1.64

51.81

2834

3972

(3024354) Oxygen [Partial pressure] in Venous blood

2304

2645

6.70

307.65

5.8

2.6

4.83

4.54

kpa

5.17

2216

2566

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

10307

52099

2.39

307.65

6.0

3.9

2.08

2.30

mu/l

1.32

9644

46890

(3027273) Bicarbonate [Moles/volume] in Venous blood

1434

1650

6.26

307.65

6.4

2.4

25.35

25.59

mmol/l

1.17

1396

1613

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

4408

10227

3.74

307.65

3.7

1.6

1.52

1.20

mg/l

5.14

3672

7822

(3020779) Urea [Moles/volume] in Serum or Plasma

3396

2748

10.57

307.65

16.7

4.1

12.51

7.13

mmol/l

197.24

3286

2628

(3024928) Oxygen saturation in Venous blood

808

568

9.85

307.65

5.9

3.0

—

(3023368) Bacteria identified in Blood by Culture

6374

12697

5.46

307.65

6.8

3.9

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1974

2501

5.90

307.65

13.6

5.8

24.87

25.05

mmol/l

0.88

1959

2476

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1950

2338

6.24

307.65

6.0

2.9

2.50

1.79

mmol/l

8.87

1500

1805

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5232

17095

2.67

307.65

4.1

3.1

44.74

34.90

u/l

2.68

4968

16241

(3013512) EKG study

4627

14537

2.67

307.65

6.8

2.5

—

(3021960) Folate [Moles/volume] in Serum or Plasma

4120

10503

3.29

307.65

1.9

1.4

18.67

21.26

nmol/l

19.59

3675

8783

(3018010) Neutrophils/100 leukocytes in Blood

7249

26598

2.76

307.65

8.8

5.7

61.93

55.79

303.10

6952

24904

(3006315) Basophils [#/volume] in Blood

7761

27434

3.09

307.65

8.4

5.8

0.04

e9/l

6.85

6888

23628

(36304419) Bacteria [Presence] in Urine

4586

13830

2.80

307.65

4.6

2.5

—

(3007853) Bacteria identified in Skin by Aerobe culture

2736

5411

3.92

307.65

2.6

1.6

—

(3020682) Albumin/Creatinine [Ratio] in Urine

5596

8083

7.17

307.65

5.0

3.0

25.70

3.67

mg/mmol

57.71

4068

4296

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1641

2120

5.65

307.65

17.9

7.9

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1363

1562

6.25

307.65

5.6

2.4

1.38

1.34

0.38

1353

1552

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1795

2238

5.92

307.65

11.1

5.8

24.81

24.85

mmol/l

0.13

1730

2110

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

3198

2204

12.24

307.65

5.2

1.8

387.32

90.32

ng/l

75.89

3056

1947

(3012095) Magnesium [Moles/volume] in Serum or Plasma

4507

7165

5.75

307.65

6.0

3.6

0.81

0.83

mmol/l

14.75

4324

6679

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

965

1571

4.26

303.06

1.6

1.5

189.03

252.93

titre

0.44

(3012441) Differential panel - Pleural fluid

501

417

8.13

299.35

1.6

1.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1002

1708

4.07

296.88

2.1

2.4

7.64

7.08

g/l

13.79

918

1522

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1001

1705

4.07

296.87

2.1

2.4

3.82

3.74

g/l

0.53

914

1520

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1001

1707

4.07

296.41

2.1

2.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2095

5713

2.66

296.00

2.2

1.4

—

(3022806) Fractional oxyhemoglobin in Capillary blood

515

456

7.65

293.71

2.3

1.5

89.09

89.85

1.42

505

448

(3028026) IgM [Mass/volume] in Serum or Plasma

1354

2881

3.31

293.60

2.0

2.1

1.18

1.48

g/l

3.99

1259

2607

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

11254

60567

2.56

291.37

36.7

10.4

25.29

25.16

mg/l

0.17

10543

44569

(3005719) IgG [Mass/volume] in Serum or Plasma

1591

3787

2.99

287.27

3.0

10.56

10.49

g/l

0.18

1495

3447

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

711

926

5.25

287.04

2.0

1.2

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

618

700

6.01

286.09

4.2

2.1

3393.81

18593.00

u/ml

0.69

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

5469

22716

1.99

282.44

3.0

2.0

73.28

4117.03

nmol/l

0.50

4971

20312

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

933

1575

4.09

279.49

2.1

2.5

10.20

10.38

g/l

0.43

844

1379

(3028308) Erythrocytes [#/volume] in Pleural fluid

487

428

7.69

279.24

1.6

1.4

40224.20

56719.91

e6/l

0.54

305

266

(3015736) pH of Urine

5037

20408

2.00

277.74

4.5

2.7

5.74

5.84

0.75

154

1844

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

700

931

5.14

276.34

1.9

1.2

17.78

25.89

u/ml

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

657

824

5.44

275.50

2.0

1.2

122.68

114.01

u/ml

0.56

129

175

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

941

1627

4.00

273.21

2.1

2.4

3.15

2.84

g/l

11.93

855

1441

(3024932) HLA-DR beta [Type]

276

21.42

272.45

1.0

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

690

920

5.12

271.61

1.5

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

690

920

5.12

271.61

1.5

1.3

—

(3037522) Nuclear Ab [Titer] in Serum

2314

6893

2.45

271.44

1.4

1.3

534.22

535.41

titre

0.01

495

1365

(3019550) Sodium [Moles/volume] in Serum or Plasma

11436

62568

2.57

270.95

46.8

10.0

139.09

139.95

mmol/l

195.27

11303

60326

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

648

818

5.40

269.89

1.9

1.7

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

791

1200

4.52

269.75

1.5

1.4

11.27

15.46

iu/ml

0.35

(3047181) Lactate [Moles/volume] in Blood

797

1224

4.47

267.88

8.7

5.0

1.43

1.24

mmol/l

3.90

725

1060

(3024471) HLA-A [Type]

277

20.09

267.50

1.0

—

(3003181) Sodium [Moles/volume] in Urine

520

527

6.68

265.61

1.5

1.3

57.01

67.71

mmol/l

3.90

402

406

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

540

572

6.40

265.44

1.7

1.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

653

846

5.26

264.79

1.6

1.5

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

11440

62773

2.55

264.62

47.3

10.0

4.06

3.97

mmol/l

197.40

11300

60343

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

770

1164

4.53

263.58

1.8

1.6

0.24

0.23

g/l

3.33

736

1102

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1607

4041

2.82

262.21

7.4

3.3

1.21

1.23

mmol/l

26.94

1501

3470

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

783

1220

4.40

258.54

1.8

1.5

1.17

1.15

g/l

1.00

751

1159

(3045788) Cell count panel - Pleural fluid

426

347

8.26

258.33

1.6

1.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

625

802

5.30

255.84

1.5

1.2

297.30

250.56

u/ml

2.70

456

495

(3017817) Protein [Mass] in Urine collected for unspecified duration

344

204

11.30

255.64

2.3

2.1

0.23

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

416

333

8.40

255.43

1.4

1.2

350.34

760.42

u/l

1.62

397

315

(3037756) Immunofixation for Serum or Plasma

654

880

5.06

254.75

1.5

2.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

854

1460

4.02

251.15

2.2

2.6

0.64

1.17

g/l

2.67

737

1247

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

937

1719

3.76

250.88

2.8

2.6

—

(3036782) Glucose [Moles/volume] in Pleural fluid

415

347

8.04

246.84

1.5

1.3

7.29

5.38

mmol/l

19.74

396

313

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

617

814

5.15

245.29

1.7

1.3

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

773

1254

4.22

242.76

2.1

2.3

0.03

0.04

g/l

0.24

702

1152

(40768806) Pleura Pathology biopsy report

457

444

6.94

241.70

1.6

1.4

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

641

892

4.89

240.63

1.5

1.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

990

1944

3.52

240.57

2.5

1.9

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

930

1753

3.66

239.57

2.3

1.7

—

(40768446) Kidney Pathology biopsy report

216

31.90

238.84

1.9

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

497

552

6.08

233.86

1.2

1.4

39.23

49.83

u/l

0.59

453

471

(3029937) Albumin [Presence] in Urine by Test strip

3581

13551

2.00

229.81

5.8

3.2

0.00

estimate

0.03

1353

4432

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1494

3884

2.71

227.54

4.1

2.4

49.53

76.09

ml/min/173m2

97.91

776

1249

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

545

686

5.38

227.24

1.6

1.3

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

715

1153

4.23

225.95

2.0

2.3

0.00

g/l

-0.00

646

1052

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

768

1313

4.00

225.41

2.0

2.3

35.47

38.91

g/l

32.41

683

1121

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

705

1134

4.24

223.45

2.1

2.4

0.00

g/l

-0.00

645

1050

(46235355) HIV 1 and 2 tests - Meaningful Use set

2261

7223

2.27

222.93

2.2

1.6

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

3202

11747

2.04

222.66

4.7

2.9

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

426

435

6.59

215.89

2.3

2.6

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1739

5010

2.46

215.10

3.0

2.4

34.09

42.85

u/l

1.47

1479

4371

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

503

621

5.47

213.74

1.6

1.3

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

587

844

4.71

212.20

1.2

50.00

138.75

titre

—

(3017181) Myelocytes/100 leukocytes in Blood

1605

4489

2.53

210.87

5.1

4.3

0.98

1.02

0.27

741

1560

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

416

427

6.55

209.85

1.2

1.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

681

1133

4.09

206.69

1.7

1.4

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

268

150

11.91

205.49

21.4

1.3

891.68

4668.23

mg/l

0.75

227

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

543

751

4.89

204.86

1.8

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

543

751

4.89

204.86

1.8

1.7

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

498

635

5.29

204.75

6.9

1.7

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

443

502

5.94

204.42

1.8

1.5

—

(3002179) Metamyelocytes/100 leukocytes in Blood

1473

4060

2.55

198.74

4.8

4.1

0.75

0.01

651

1358

(3000012) Reticulocyte production index

462

570

5.46

196.33

2.4

2.6

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

322

267

8.06

192.51

1.4

1.3

11.11

17.14

u/l

2.29

279

250

(21494890) Protein electrophoresis panel - 24 hour Urine

363

354

6.87

191.16

1.7

2.7

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

708

1289

3.74

190.55

1.5

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

487

657

5.00

188.62

1.7

1.3

—

(3021440) Promyelocytes/100 leukocytes in Blood

1498

4287

2.45

186.36

5.2

4.3

0.08

0.13

2.14

637

1360

(3039000) Anion gap in Blood

560

869

4.36

184.99

10.0

5.9

11.61

10.93

mmol/l

3.24

520

769

(3018572) Chloride [Moles/volume] in Blood

560

869

4.36

184.99

10.0

5.9

103.98

105.29

mmol/l

5.71

520

769

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

4583

19978

1.77

181.21

5.6

3.0

—

(3011985) Renin [Units/volume] in Plasma

320

290

7.37

178.78

1.5

1.7

94.01

60.25

mu/l

0.49

281

266

(3035880) pH of Pleural fluid

263

181

9.68

178.58

1.4

1.2

—

(3004451) EKG impression Narrative

224

117

12.72

178.06

1.4

1.2

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

393

455

5.79

177.59

1.8

1.4

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

393

455

5.79

177.59

1.8

1.4

—

(3025159) Blasts/100 leukocytes in Blood

1416

4033

2.45

177.50

5.2

4.4

0.18

0.38

0.74

556

1125

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1321

3639

2.53

177.47

1.6

1.4

—

(3052851) Hemolysis interference index of Serum or Plasma

703

1343

3.56

176.64

5.0

2.6

—

(3040151) Glucose [Moles/volume] in Capillary blood

366

406

6.04

172.12

9.4

3.8

7.39

7.05

mmol/l

0.79

321

348

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2626

9755

1.95

170.12

3.2

3.4

2.47

2.45

mmol/l

19.76

2255

8616

(40761535) Cells panel - Urine sediment

1352

3846

2.45

169.55

4.7

2.7

—

(3004775) Volume in Urine collected for unspecified duration

239

155

10.25

168.36

2.6

1.7

753.33

673.33

1.05

172

105

(3037121) Protein [Mass/volume] in Urine

746

1539

3.30

167.05

3.9

2.9

0.52

0.17

g/l

14.74

425

630

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

465

678

4.61

165.09

1.3

—

(3000494) Fungus identified in Specimen by Culture

1974

6732

2.08

160.94

1.8

1.4

—

(3034770) Mitochondria Ab [Titer] in Serum

645

1245

3.51

159.43

1.2

1.3

880.00

928.60

titre

0.06

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

283

256

7.37

158.29

1.3

329.91

402.76

pmol/l

0.28

241

225

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

7747

39930

1.66

156.83

4.7

2.6

82.82

43.26

u/l

123.27

7275

37163

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

316

332

6.35

156.01

1.8

1.5

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

147

24.92

152.41

10.1

5.2

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

293

296

6.60

149.66

1.6

1.4

14.05

11.06

u/l

6.65

279

285

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

462

730

4.25

149.04

3.4

1.5

1.05

0.68

nmol/l

12.10

361

621

(3007566) Smooth muscle Ab [Titer] in Serum

636

1273

3.38

148.86

1.2

1.3

114.85

186.58

titre

0.61

111

(3017569) Oxygen content in Arterial blood

211

138

10.15

147.85

2.4

2.2

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

10403

58485

1.80

147.49

33.6

9.3

70.41

83.90

ml/min/173m2

307.65

9384

46594

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

10327

57936

1.79

147.36

5.3

3.2

1.48

1.20

mmol/l

201.51

9568

52675

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

10434

58722

1.81

147.20

6.0

3.4

6.57

5.66

mmol/l

307.65

9583

53202

(40761536) Microorganisms panel - Urine sediment

1361

4168

2.27

143.74

6.2

3.2

—

(3007164) IgA [Mass/volume] in Serum or Plasma

2584

10046

1.85

142.91

1.8

1.5

2.94

2.42

g/l

18.41

1723

5924

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

652

1373

3.22

141.02

1.5

1.2

—

(3006576) Bicarbonate [Moles/volume] in Blood

168

14.07

140.57

8.2

3.9

25.59

25.66

mmol/l

0.04

154

(3016750) Collection duration of Urine

191

115

11.01

140.55

2.5

1.6

488.77

502.47

min

0.57

146

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

448

725

4.15

140.26

1.3

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

133

25.09

138.20

10.3

5.5

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

188

115

10.83

137.08

1.2

1.1

—

(40768797) Stomach Pathology biopsy report

2057

7518

1.94

136.54

1.3

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

262

261

6.68

135.42

1.4

1.1

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

190

121

10.40

135.29

1.6

1.2

63.08

60.98

0.22

148

(3019977) pH of Arterial blood

226

187

8.02

135.25

3.2

2.5

7.42

7.43

0.84

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

181

110

10.90

132.48

1.2

1.1

—

(3023419) Bacteria identified in Sputum by Culture

439

739

3.98

130.67

2.2

2.7

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

434

730

3.99

129.31

1.5

1.2

4.35

3.40

u/ml

0.78

211

323

(40757494) Bilirubin.total [Moles/volume] in Blood

200

152

8.72

127.13

2.5

2.0

20.59

24.51

umol/l

0.19

(3044242) Glucose [Moles/volume] in Arterial blood

195

143

9.04

126.99

2.5

1.9

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

229

210

7.24

126.68

1.3

1.4

1.73

1.16

nmol/l

7.29

201

189

(4200892) Spirometry reversibility

1181

3642

2.23

121.80

1.6

1.4

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

10741

61948

1.75

121.25

6.4

3.8

2.32

3.10

mmol/l

307.65

10043

56498

(40761511) CBC panel - Blood by Automated count

11052

64306

1.81

120.46

33.2

9.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

428

759

3.78

118.84

1.4

1.2

5.35

3.68

u/ml

0.53

152

271

(3014148) Varicella zoster virus Ab [Titer] in Serum

347

529

4.38

116.77

1.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

10568

60917

1.70

115.02

5.8

3.6

4.11

5.08

mmol/l

307.65

9897

55899

(3000093) Morphology [Interpretation] in Blood Narrative

295

398

4.94

114.02

1.2

1.1

—

(3002385) Erythrocyte distribution width [Ratio]

9417

52814

1.59

112.75

41.0

12.5

15.75

14.83

11.31

9313

51693

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

188

157

7.93

111.74

2.4

1.7

176.83

143.96

3.75

176

143

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

10482

60439

1.68

111.27

5.7

3.5

1.27

1.56

mmol/l

307.65

9762

55393

(3041096) Erythrocytes [Presence] in Urine by Automated

3206

14109

1.64

110.68

5.0

2.7

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

168

122

9.11

110.13

2.6

2.7

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

353

573

4.11

109.98

1.1

—

(3012565) Volume of 24 hour Urine

184

154

7.91

109.19

2.5

2.8

1732.72

2093.90

2.79

166

142

(21494755) Public health laboratory ask at order entry panel

341

6883

0.31

108.69

1.3

—

(3019150) Specific gravity of Urine by Refractometry

2602

10897

1.70

108.00

5.7

3.2

1.02

kg/l

0.64

388

1561

(3001893) Eosinophils/100 leukocytes in Pleural fluid

152

10.25

107.44

1.6

1.2

2.77

4.39

0.80

124

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

289

405

4.75

107.14

1.3

4.35

0.58

nmol/l

0.52

274

389

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

288

404

4.74

106.65

1.3

0.17

0.50

nmol/l

0.98

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

335

6750

0.31

106.26

1.7

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

327

516

4.22

105.52

1.2

61.97

65.76

u/l

0.25

300

450

(3008037) Lactate [Moles/volume] in Venous blood

446

886

3.37

105.24

5.2

2.2

1.63

1.46

mmol/l

2.38

427

871

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1744

6537

1.86

104.99

2.0

1.6

1.72

1.40

35.68

1455

5845

(3030981) Hyaline casts [#/volume] in Urine by Automated count

911

2674

2.32

104.81

3.9

2.3

0.41

0.27

e6/l

1.15

895

2602

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

568

1315

2.91

104.60

1.5

1.4

—

(3051593) INR in Capillary blood by Coagulation assay

142

10.78

103.45

14.0

4.2

—

(3042631) Mycobacterium sp identified in Specimen

384

697

3.68

103.21

2.5

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

397

738

3.60

103.20

1.4

1.1

100.05

119.24

15.57

378

663

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

266

358

4.94

103.07

1.3

—

nmol/l

—

(3045716) Anion gap in Serum or Plasma

172

146

7.79

101.01

3.7

1.9

9.28

9.66

mmol/l

0.47

167

138

(3024891) Influenza virus A+B Ag [Presence] in Specimen

560

1313

2.87

100.82

1.3

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

283

411

4.58

100.77

1.1

1.0

—

(3044927) Protein electrophoresis panel - Urine

280

403

4.62

100.73

1.2

1.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

338

569

3.96

100.50

1.4

1.1

91.22

96.38

2.15

325

529

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

11276

66788

1.76

100.41

19.0

8.4

29.62

25.78

u/l

7.78

11024

64008

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

265

366

4.81

99.84

1.3

—

(3051651) Icteric interference index of Serum or Plasma

221

258

5.68

98.98

6.3

3.5

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

272

391

4.62

97.99

1.9

1.4

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

135

10.36

96.12

2.0

1.9

102.68

12.38

ug/min

1.48

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

285

434

4.37

96.01

1.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

285

434

4.37

96.01

1.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

285

434

4.37

96.01

1.8

—

(3016038) Potassium [Moles/volume] in Urine

189

194

6.45

95.22

1.2

1.3

33.58

36.81

mmol/l

0.70

169

168

(3042111) Morphology [Interpretation] in Bone marrow Narrative

419

855

3.28

94.86

1.5

1.7

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

394

773

3.41

94.68

1.3

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

239

316

5.02

94.39

1.7

1.4

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

139

9.27

92.31

1.5

1.2

17.17

13.40

g/l

2.95

118

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

282

443

4.23

91.49

4.1

2.4

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

170

164

6.85

90.28

2.4

1.6

1539.14

4205.80

e6/l

0.42

133

(3000919) Neutrophils/100 leukocytes in Pleural fluid

129

10.01

90.00

1.6

1.2

22.32

25.18

0.34

112

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

160

144

7.34

89.86

2.2

1.5

27158.25

9709.12

e6/l

0.75

(44816559) Phosphatidylethanol [Mass/volume] in Blood

380

755

3.36

89.59

1.4

1.3

—

(3025941) Bacteria identified in Stool by Culture

923

2908

2.16

89.41

1.4

1.2

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

18.40

89.14

1.4

5.76

1072424.97

nmol/l

0.87

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

209

257

5.39

88.97

1.3

1.2

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

298

503

3.94

88.29

1.9

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

3147

14428

1.56

88.29

1.7

1.6

1.55

1.26

mmol/l

43.71

2665

12216

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

216

277

5.17

88.10

1.8

1.4

—

(3051611) Lipemic interference index of Serum or Plasma

292

487

3.99

87.87

5.6

2.6

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

216

278

5.15

87.77

1.8

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

311

545

3.80

87.68

1.8

1.9

—

(3000492) Spirometry study

1470

5516

1.84

87.09

1.6

1.4

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

424

925

3.06

86.24

1.3

1.2

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

180

196

6.08

86.06

1.2

1.1

2.70

3.25

iu/ml

—

(3019225) pH of Specimen

1484

5611

1.82

85.73

8.9

3.4

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

107

117.56

85.00

4.9

1.2

—

(3004809) Band form neutrophils/100 leukocytes in Blood

407

879

3.09

84.16

3.9

3.4

1.42

1.82

1.27

369

779

(3038515) Glucose [Moles/volume] in Venous blood

398

848

3.13

84.13

5.6

2.3

8.08

6.97

mmol/l

9.13

381

842

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

293

509

3.83

83.58

2.8

2.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

188

4482

0.26

80.18

1.5

1.4

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

21.31

80.06

7.9

6.2

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

20.49

79.01

4.7

3.1

56.51

32.74

ug/min

2.44

(3033799) Differential panel - Peritoneal fluid

146

143

6.74

76.59

2.5

1.5

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

202

278

4.81

76.43

1.3

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

109

9.97

75.95

1.2

155.18

146.52

mmol/24h

0.32

109

(3002331) Protein [Mass/volume] in Peritoneal fluid

119

8.72

75.94

1.6

1.3

28.40

24.67

g/l

1.02

101

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

13.46

75.55

6.6

7.6

67.59

61.73

0.47

(4146454) Self-monitoring of blood glucose

216

321

4.46

74.92

2.9

2.6

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

13.16

74.74

1.5

1.3

11.85

8.67

0.41

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

179

225

5.26

74.56

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

179

225

5.26

74.56

1.5

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1601

6451

1.71

73.73

15.3

4.3

—

(3000475) Leukocytes [#/volume] in Synovial fluid

484

1242

2.61

73.48

1.7

20274.43

12864.12

e6/l

1.29

334

909

(3021788) Differential panel - Synovial fluid

403

943

2.85

72.67

1.6

1.5

—

(3008295) Osmolality of Serum or Plasma

239

399

3.97

71.86

1.4

277.33

281.51

mosm/kgh2o

1.29

185

315

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

15.41

71.67

2.5

2.1

110.49

22.54

mg/l

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

10.71

69.84

1.3

1.2

71.95

121.89

ng/l

0.43

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

535

1479

2.42

69.73

1.8

1.6

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

329

700

3.13

69.69

2.3

2.7

9.86

8.35

titre

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

362

817

2.95

69.51

1.1

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

117

7.87

69.45

1.5

1.2

25.82

20.35

0.79

(3023383) Lactate [Moles/volume] in Pleural fluid

130

126

6.80

68.82

1.4

1.2

2.95

4.17

mmol/l

2.11

115

114

(3017704) Immunofixation for Urine

168

215

5.16

68.72

1.5

2.2

—

(3044007) Cell count panel - Peritoneal fluid

133

6.60

68.59

2.5

1.6

—

(3034426) Prothrombin time (PT)

146

163

5.91

68.27

1.4

1.1

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

229

387

3.92

67.78

1.2

183.20

173.38

titre

0.05

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

228

387

3.90

67.10

1.2

250.00

62.50

titre

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

426

1076

2.64

66.67

1.5

1.4

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

319

686

3.09

66.41

1.1

1.64

1.49

g/l

6.19

291

614

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

402

988

2.71

66.27

1.7

4.00

4.64

iu/l

0.48

123

319

(3003694) ABO and Rh group [Type] in Blood

3298

16050

1.46

66.23

1.4

1.3

—

(3047189) Immunofixation for 24 hour Urine

151

182

5.48

65.63

1.5

2.3

—

(3005322) IgE [Units/volume] in Serum or Plasma

904

3174

1.93

64.81

1.3

278.05

232.09

u/ml

0.54

834

2921

(3041918) Cholesterol [Moles/volume] in Pleural fluid

10.09

64.62

1.3

1.2

1.12

2.19

mmol/l

6.72

(3014891) Appearance of Pleural fluid

11.76

64.41

1.4

1.3

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

192

294

4.32

64.31

1.2

128.03

93.43

u/l

2.28

175

251

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

189

287

4.35

63.95

1.5

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

187

283

4.37

63.53

1.5

1.4

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

532

1556

2.29

61.15

1.5

1.4

241.78

267.10

ug/g

2.01

344

909

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

351

839

2.78

60.91

1.1

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2474

11567

1.49

59.85

1.3

1.2

1.89

2.12

u/ml

0.26

622

3064

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

8.74

59.58

1.5

1.1

80.89

84.44

0.18

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

184

290

4.19

59.53

1.2

37.16

18.81

u/l

4.38

164

239

(3035637) Corticotropin [Mass/volume] in Plasma

284

609

3.09

59.42

1.7

1.5

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

14.63

58.95

1.3

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

111

108

6.77

58.61

1.3

37.99

320.79

ug/l

1.07

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

8.65

58.51

1.5

1.1

76.69

72.35

0.36

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

489

1414

2.31

57.67

1.3

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

493

1434

2.30

57.37

1.3

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

491

1426

2.30

57.34

1.3

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

164

244

4.44

56.88

3.2

2.5

155.05

34.92

mg/l

1.86

127

148

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

107

104

6.77

56.56

1.7

1.6

5.25

2.92

nmol/l

0.75

(3027923) C peptide [Moles/volume] in Serum or Plasma

137

174

5.19

56.53

1.4

1.5

1.31

1.16

nmol/l

0.56

141

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

105

100

6.91

56.44

3.8

2.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

105

100

6.91

56.44

3.8

2.4

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

185

309

3.96

55.65

1.0

1.1

305.62

285.30

mg/l

2.42

165

280

(3015171) Extractable nuclear Ab [Units/volume] in Serum

598

1909

2.10

55.53

1.3

1.2

2.29

1.10

u/ml

0.70

161

(3009871) Measles virus Ab [Titer] in Serum

146

202

4.77

55.01

1.2

1.8

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

12.59

54.89

1.3

49.43

1062.58

u/l

0.59

(3049717) Cytology report of Urine Cyto stain

608

1973

2.06

54.09

2.6

2.9

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

166

262

4.18

53.65

2.2

1.9

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

239

491

3.22

53.57

4.1

1.8

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

10.06

52.65

1.4

1.2

0.92

1.99

mmol/l

0.62

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

244

515

3.14

52.40

3.4

4.0

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

203

384

3.50

51.53

1.7

1.4

1.20

1.52

promille

1.83

152

298

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

150

226

4.38

51.29

3.2

3.7

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

121

150

5.31

51.21

1.7

2.2

72.90

136.40

umol/l

1.68

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

209

414

3.34

49.57

1.1

1.4

—

(3044941) Cell count panel - Synovial fluid

312

783

2.64

49.45

1.4

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

132

187

4.65

48.48

1.9

1.4

21429.05

1355.69

u/ml

0.46

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

258

593

2.88

48.06

1.1

54.62

17459.51

iu/ml

0.53

134

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

12.31

47.20

1.2

1.1

16.61

24.21

u/l

1.17

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

151

245

4.07

47.20

1.2

1.1

47.23

22.41

u/l

2.41

137

219

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

265

626

2.80

47.02

1.6

67.45

55.51

4.44

171

410

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

4376

23383

1.34

46.79

4.2

4.4

2.89

3.23

ug/l

0.47

3859

21362

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

143

226

4.17

46.19

1.6

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

143

226

4.17

46.19

1.6

1.5

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

28.21

46.08

15.2

3.7

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

150

247

4.01

46.02

1.2

1.1

116.81

76.93

u/l

2.34

136

224

(3024980) IgG subclass 4 [Mass/volume] in Serum

326

873

2.48

45.41

1.5

1.6

0.77

0.91

g/l

0.67

245

666

(3045414) Leukocytes [Presence] in Urine

653

2317

1.89

45.05

2.4

1.7

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

126

183

4.54

45.02

1.7

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

738

2725

1.82

44.96

2.5

2.3

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

166

302

3.63

44.59

1.4

1.5

20.21

19.41

u/ml

0.07

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

11.39

44.54

1.6

1.4

68.98

82.68

1.59

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2003

9469

1.45

44.30

1.3

1.2

38.29

41.54

iu/ml

0.27

640

3122

(3022621) pH of Urine by Test strip

857

3327

1.73

44.08

3.8

2.4

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

124

183

4.46

43.50

2.5

2.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

11462

70797

1.48

43.49

52.6

14.7

38.93

41.11

45.00

10789

66218

(4035726) Immunohistochemistry procedure

1388

6105

1.54

43.48

1.8

1.4

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

287

738

2.58

43.41

2.2

2.6

59.79

862.26

u/ml

1.17

279

731

(3000330) Specific gravity of Urine by Test strip

682

2485

1.84

43.32

4.6

2.7

—

(44786800) Granulocytes/100 leukocytes in Body fluid

8.80

43.22

1.3

1.1

19.06

30.99

1.17

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

126

190

4.37

43.11

4.4

1.3

21.12

733.69

ug/l

0.87

121

180

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

167

313

3.52

43.02

1.6

1.5

9.52

5.38

u/l

1.74

128

242

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1036

4265

1.64

42.81

1.4

1.5

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

499

1641

2.03

42.78

1.6

11.91

2.95

iu/ml

0.41

118

353

(3007461) Platelets [#/volume] in Blood

11462

70868

1.47

42.19

51.0

14.7

240.20

248.75

e9/l

30.25

11264

68314

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1496

6738

1.51

41.92

3.2

4.6

13.11

31.42

ug/l

3.28

1253

5438

(21494434) Karyotype in Bone marrow

218

495

2.91

41.53

1.2

—

(3035941) MCH [Entitic mass]

11463

70933

1.46

41.15

50.8

14.6

30.30

30.42

8.47

11350

69594

(3024731) MCV [Entitic volume]

11463

70953

1.46

40.80

50.8

14.6

92.12

91.16

75.24

11350

69601

(3010813) Leukocytes [#/volume] in Blood

11464

70962

1.46

40.77

51.0

14.7

7.54

6.30

e9/l

307.65

11241

68171

(3026361) Erythrocytes [#/volume] in Blood

11463

70962

1.46

40.63

51.0

14.7

4.32

4.55

e12/l

298.84

11245

68178

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

283

751

2.50

40.20

1.1

—

(3000963) Hemoglobin [Mass/volume] in Blood

11464

70995

1.46

40.18

51.5

14.7

129.40

137.91

g/l

307.65

11359

69652

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

102

5.67

39.85

1.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

246

611

2.66

39.83

4.8

4.1

—

(3045142) Bone marrow Pathology biopsy report

261

683

2.53

38.16

1.3

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

258

673

2.54

37.97

1.6

1.5

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

7.47

37.88

1.5

1.3

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

123

5.03

37.72

1.2

1.1

87.55

104.06

2.10

114

(3024522) Salmonella sp identified in Specimen by Organism specific culture

254

662

2.54

37.45

1.6

1.5

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

154

301

3.37

37.37

2.0

2.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

154

301

3.37

37.37

2.0

2.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

253

660

2.54

37.24

1.6

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

251

655

2.54

36.92

1.6

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

250

654

2.53

36.59

1.6

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

250

655

2.52

36.48

1.6

1.5

—

(3010838) Calcium [Moles/time] in 24 hour Urine

309

895

2.29

36.34

1.8

2.1

4.31

5.66

mmol/24h

8.40

274

778

(3028192) IgG subclass 2 [Mass/volume] in Serum

219

539

2.69

36.12

1.5

1.3

2.63

2.98

g/l

1.80

152

383

(4062490) Immunoglobulin typing, IgG

219

542

2.67

35.74

1.5

1.3

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

218

539

2.67

35.65

1.5

1.3

0.51

0.41

g/l

0.68

152

382

(3027135) IgG subclass 1 [Mass/volume] in Serum

218

539

2.67

35.65

1.5

1.3

7.57

6.98

g/l

0.79

151

383

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

347

1073

2.15

34.92

1.2

8.51

13.53

u/ml

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

123

4.81

34.51

1.1

75.40

91.91

3.11

(3017354) Segmented neutrophils/100 leukocytes in Blood

214

535

2.64

34.28

3.3

3.7

60.78

53.42

4.39

185

447

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

+∞

34.24

15.1

0.0

137.12

—

e6/l

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

109

5.07

34.04

1.4

1.5

20.65

13.91

pmol/l

2.12

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

141

277

3.35

34.00

1.3

193.75

55.28

titre

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

9.74

33.80

2.8

1.3

62.88

59.67

0.16

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

144

288

3.29

33.79

1.3

337.14

120.00

titre

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

188

442

2.81

33.76

1.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

342

1069

2.12

33.51

1.3

1.2

9.29

4.07

u/ml

0.36

(3014271) Vancomycin [Susceptibility]

120

213

3.71

33.46

3.4

2.9

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

122

4.74

33.23

1.1

73.00

90.39

2.51

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

277

797

2.30

33.11

1.8

2.1

21.36

24.71

ug/l

0.66

268

786

(21491868) Cryoglobulin [Mass/volume] in Serum

150

4.30

33.03

1.3

1.2

0.13

0.40

g/l

—

(3023420) DNA double strand Ab [Units/volume] in Serum

212

539

2.60

32.89

1.8

1.4

23.24

26.95

iu/ml

0.13

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

+∞

32.48

5.7

0.0

427.54

—

umol/l

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

189

458

2.72

32.14

2.1

2.0

5.66

3.05

mg/l

6.73

180

441

(3009466) Valproate [Moles/volume] in Serum or Plasma

265

760

2.31

31.92

5.6

4.9

362.98

369.91

umol/l

0.34

243

635

(3001019) Free T4 and TSH panel - Serum or Plasma

179

2811

0.41

31.86

1.6

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

303

921

2.18

31.84

1.1

1.2

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

413

1427

1.92

30.82

1.3

1.2

27.67

41.23

u/ml

0.46

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

124

239

3.42

30.80

4.5

2.9

—

(3022145) Colonoscopy Study observation

1442

6828

1.43

30.74

1.3

1.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

6400

37195

1.25

30.73

2.9

2.5

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

169

397

2.81

30.44

2.3

2.2

—

(40757373) Influenza virus identified in Isolate

5.24

29.85

1.7

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

7.61

29.72

1.1

797.03

368.55

pmol/l

0.61

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

386

1324

1.93

29.44

1.3

1.2

9.20

5.69

u/ml

0.68

193

(3011412) CD3 cells [#/volume] in Blood

211

566

2.46

29.42

2.4

2.6

0.93

1.23

e9/l

1.06

190

513

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

11.86

29.34

1.2

1.0

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

382

1308

1.94

29.28

1.3

1.2

3.73

3.95

u/ml

0.04

123

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

11.12

29.08

2.5

1.1

15.56

35.63

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

157

365

2.83

28.83

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

8.68

28.83

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

147

334

2.90

28.12

1.1

1.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

108

2006

0.35

28.11

1.6

1.7

—

(3033926) Protein [Mass/volume] in Peritoneal dialysis fluid

+∞

28.09

4.2

0.0

1.54

—

g/l

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

147

335

2.89

27.97

1.1

1.0

—

(3014051) Protein [Presence] in Urine by Test strip

382

1333

1.90

27.71

3.3

2.2

—

(3016244) Insulin [Units/volume] in Serum or Plasma

114

225

3.33

27.38

3.5

3.2

34.52

22.38

mu/l

1.60

103

208

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

+∞

27.21

11.2

0.0

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

5.86

27.20

2.3

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

181

470

2.54

27.01

1.5

1.6

18.86

33.03

7.09

118

303

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

152

3.89

26.90

1.4

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

150

3.90

26.68

1.7

1.2

—

(3017732) Neutrophils [#/volume] in Blood

885

3914

1.51

26.55

3.5

2.7

5.87

4.49

e9/l

1.63

686

3113

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

106

207

3.37

25.89

1.2

1.1

3.82

2.74

u/ml

0.35

(3010144) Erythrocytes [#/volume] in Synovial fluid

182

489

2.45

25.36

1.4

126406.46

82501.07

e6/l

0.29

119

346

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

6.31

25.09

1.0

—

(1175426) CD3 cells/100 lymphocytes in Blood

169

442

2.52

24.89

2.1

2.2

73.46

71.82

0.58

159

427

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

+∞

24.58

10.1

0.0

42.87

—

(3019832) Treponema pallidum Ab [Presence] in Serum

649

2725

1.59

24.51

1.9

1.6

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

165

432

2.52

24.27

2.1

2.2

14.50

16.43

1.38

159

425

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

188

3.39

24.00

3.6

1.7

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

459

4865

0.60

23.92

1.3

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

4.79

23.80

1.7

1.5

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

5.31

23.51

2.8

1.3

221.42

72.76

ng/l

4.18

(3026389) Candida sp identified in Specimen by Organism specific culture

219

663

2.18

23.36

1.3

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

5.05

23.19

1.1

4.72

2.49

pmol/l

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1746

8903

1.33

23.14

1.3

1.2

14.75

14.55

u/ml

0.02

618

3412

(3045424) Erythrocytes [Presence] in Urine

269

888

2.00

22.95

1.8

1.4

—

(40768443) Skin Pathology biopsy report

609

2559

1.58

22.93

1.3

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

143

360

2.62

22.76

2.0

1.8

1.55

2.31

u/field

0.95

153

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

902

8220

0.70

22.66

1.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

199

590

2.22

22.33

1.1

—

(36660697) Celiac disease serology panel - Serum

912

4202

1.45

22.26

1.2

1.1

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

7.09

22.14

1.4

2.7

0.85

2.00

mmol/l

1.67

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

4.90

22.06

2.1

1.6

7.55

6.95

mmol/l

0.58

(37021550) Renin [Units/volume] in Plasma --upright

6.41

21.91

1.2

1.4

157.56

54.42

mu/l

1.36

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

4.94

21.88

2.4

1.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

5.92

21.83

1.0

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

584

2460

1.58

21.76

1.3

1.4

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

11.18

21.69

7.6

2.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

115

266

2.84

21.43

1.1

1.08

1.06

ratio

0.37

(1761868) Lipid panel - Serum or Plasma

2991

22979

0.81

21.37

3.8

2.4

—

(1761482) Bacteria [#/volume] in Urine by Culture

343

1260

1.80

21.27

5.6

3.3

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

7.91

21.05

1.1

1.0

12.78

3.40

iu/ml

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

112

258

2.85

21.04

1.8

1.7

2.53

3.08

u/field

0.23

179

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

337

1238

1.80

20.91

1.2

1.3

157.31

212.04

miu/ml

1.45

591

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1470

7424

1.33

20.67

5.4

3.6

32.14

31.72

0.71

1172

4575

(3004616) Nuclear Ab [Presence] in Serum

199

612

2.14

20.48

1.3

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

110

257

2.81

20.17

2.2

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

206

648

2.10

20.03

1.3

1.2

68.35

57.88

u/ml

0.17

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

110

260

2.78

19.76

1.2

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

207

657

2.08

19.68

3.0

1.9

26.37

27.52

mg/l

0.08

157

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

108

254

2.80

19.58

2.3

2.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

108

254

2.80

19.58

2.3

2.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

167

3.26

19.49

1.2

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

6.39

19.33

1.5

1.7

42.87

46.18

umol/l

0.28

(3002256) Pathology report gross observation

1557

8000

1.31

19.31

1.3

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

9.05

19.12

1.0

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

4.27

18.95

2.0

4.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

149

419

2.34

18.95

1.4

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

144

401

2.36

18.72

2.2

1.5

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

105

250

2.76

18.64

1.1

—

(3020491) Glucose [Moles/volume] in Blood

122

315

2.55

18.57

2.4

1.4

8.00

6.28

mmol/l

6.10

215

(3048879) Bone marrow aspiration report

163

3.22

18.45

1.5

2.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

347

1336

1.72

18.39

3.0

3.8

2052.98

418.49

u/ml

0.44

306

1223

(40761539) Cells [Type] in Urine sediment by Light microscopy

103

3.89

18.36

1.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

126

333

2.49

18.30

2.1

1.3

112.87

77.33

umol/l

3.26

126

333

(3010503) CD19 cells [#/volume] in Blood

138

383

2.37

18.09

2.4

2.8

0.21

0.14

e9/l

0.37

129

373

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

142

401

2.33

17.92

2.6

2.8

438.47

585.11

e6/l

0.85

114

338

(3024263) Appearance of Synovial fluid

110

275

2.63

17.85

1.5

1.4

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

141

3.35

17.65

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

111

281

2.60

17.59

1.2

1.3

10.89

7.62

mmol/l

8.20

266

(40768441) Liver Pathology biopsy report

139

393

2.33

17.51

1.6

1.2

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

5.66

17.37

1.1

1.2

0.84

0.67

umol/24h

0.64

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

180

574

2.07

16.97

1.3

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

3.82

16.79

1.2

1.4

—

(4281824) Cell count and differential, peritoneal fluid

200

666

1.98

16.78

1.4

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

538

2361

1.51

16.73

2.5

3.8

468.60

1001.02

u/ml

1.13

452

2020

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

+∞

16.67

3.9

0.0

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

153

463

2.17

16.48

1.6

1.5

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

139

405

2.26

16.38

1.2

36.07

34.67

u/ml

0.03

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

10.04

16.17

1.0

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

3.91

16.11

1.2

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

138

405

2.24

16.01

1.2

51.11

86.33

u/ml

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

124

3.39

15.98

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

6.01

15.94

1.5

1.2

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

489

2125

1.52

15.93

1.1

62.19

3.56

u/ml

—

(3028433) Virus identified in Specimen by Culture

187

2.88

15.79

1.3

1.2

—

(3038026) Centromere Ab [Units/volume] in Serum

139

413

2.21

15.67

1.2

1.86

47.25

u/ml

—

(3022689) Creatine [Moles/volume] in Urine

4.00

15.67

1.5

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

6.55

15.62

2.5

2.0

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

248

2.60

15.60

2.7

2.6

43243.08

42062.43

ug/l

0.24

248

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

279

1060

1.74

15.56

1.3

1.2

67.38

40.93

u/ml

1.01

(21494815) CD4 cells/100 lymphocytes in Specimen

176

576

2.01

15.53

2.0

2.3

41.01

35.74

3.84

169

566

(3019768) Coxiella burnetii Ab [Presence] in Serum

8.19

15.42

1.4

1.0

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

7.74

15.42

1.3

1.4

0.53

1.36

ml/s/173m2

4.05

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

130

379

2.26

15.33

2.7

2.8

0.20

0.24

e9/l

1.00

113

332

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

184

618

1.96

15.12

1.2

1.3

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

256

2.54

15.11

1.4

1.1

199.51

617.32

u/l

1.72

242

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

132

391

2.22

15.01

1.2

6.75

2.82

u/ml

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

+∞

14.92

6.5

0.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

137

3.16

14.87

1.7

1.5

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

4.95

14.84

2.2

2.0

—

(4034850) Laboratory test

416

1777

1.55

14.67

21.5

6.3

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

4.85

14.53

1.3

1.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

4.56

14.34

1.1

1.3

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

248

2.52

14.26

1.8

2.2

16.48

13.81

umol/l

0.21

188

(40768804) Tissue Pathology biopsy report

4321

25389

1.17

14.11

2.2

2.0

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

238

2.54

14.07

1.5

1.6

2.36

3.14

0.37

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

201

2.68

13.92

2.0

2.1

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

27.50

13.90

3.4

1.2

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

27.50

13.90

3.4

1.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

4.58

13.65

2.2

1.9

—

(3008536) Aspergillus sp Ab [Presence] in Serum

136

3.04

13.37

2.0

2.4

—

(3032057) Clostridioides difficile [Presence] in Stool

3.49

13.11

2.2

1.8

—

(3048689) Calprotectin [Mass/mass] in Stool

1257

6618

1.27

12.67

2.0

2.4

184.66

126.17

ug/g

4.75

1013

5206

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

100

3.34

12.59

1.1

1.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

447

2006

1.47

12.55

1.6

1.7

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

3.76

12.51

1.4

1.1

1.21

0.87

mg/l

0.51

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

3260

18877

1.17

12.45

3.6

3.7

22.42

20.61

7.56

1450

8681

(3050129) First trimester maternal screen panel - Serum or Plasma

359

0.16

12.34

1.8

1.4

—

(3002619) Bacteria identified in Specimen by Culture

3.38

12.31

1.7

1.3

—

(37019676) Renin [Units/volume] in Plasma --supine

+∞

12.28

1.0

0.0

82.01

—

mu/l

—

(4094501) Cardiovascular stress test using bicycle ergometer

298

1229

1.60

12.28

1.1

1.0

—

(21494814) CD8 cells/100 lymphocytes in Specimen

251

2.38

12.25

1.9

2.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

348

1490

1.54

12.22

1.3

—

(3035320) C reactive protein [Mass/volume] in Body fluid

112

340

2.16

12.11

3.6

2.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

286

2.27

12.03

2.0

1.3

7.07

5.37

u/l

0.55

246

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

143

480

1.96

11.88

2.2

2.8

564.27

699.63

e6/l

0.65

127

463

(3052592) Norovirus Ag [Presence] in Stool

3.52

11.72

1.4

1.2

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

6.05

11.70

2.3

1.0

171.44

167.79

ug/g

0.03

(3006245) CD3-CD19+ cells/100 cells in Blood

189

2.57

11.68

2.4

2.3

12.71

10.39

0.40

179

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

113

350

2.12

11.64

1.7

2.2

16.80

17.80

nmol/l

0.63

105

333

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

118

372

2.08

11.62

2.5

3.1

38.60

37.50

0.23

179

(42529582) MDA5 Ab [Presence] in Serum by Line blot

120

3.01

11.53

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

120

3.01

11.53

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

120

3.01

11.53

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

120

3.01

11.53

1.0

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

147

507

1.91

11.32

1.2

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

187

702

1.75

11.02

2.0

2.1

5600.00

3148.07

titre

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

204

2.44

10.88

1.9

2.3

63.28

47.25

umol/l

2.42

176

(3019174) dRVVT (LA screen)

4.91

10.80

1.2

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

197

2.46

10.78

2.3

2.2

29.50

28.87

0.11

189

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

217

2.39

10.78

1.1

1632.46

1580.68

miu/ml

0.15

217

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

173

1913

0.59

10.78

1.4

1.3

—

(3036180) Methadone [Presence] in Urine

170

2.59

10.75

1.6

1.7

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

3.36

10.73

1.2

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

327

0.18

10.59

1.3

1.4

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

135

2.77

10.41

1.0

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

209

2.39

10.36

1.1

1.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

433

3915

0.71

10.24

1.7

1.8

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

544

0.26

10.19

1.4

1.5

—

(3028707) Methadone [Presence] in Urine by Screen method

155

564

1.81

10.17

2.5

2.9

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

240

2.27

10.14

1.4

1.5

3663113.67

1426856.07

iu/ml

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

294

1266

1.53

10.14

1.4

10.31

9.73

u/l

0.26

229

1030

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

230

936

1.62

10.09

1.7

1.5

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

258

2.21

10.03

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

109

2.95

9.99

1.0

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

209

2.35

9.96

1.0

100.97

96.67

0.40

165

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

110

2.92

9.85

1.3

30.85

40.78

0.84

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

4.22

9.83

1.5

2.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

268

0.15

9.79

1.3

1.4

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

122

416

1.93

9.78

1.4

1.2

2.25

2.05

mmol/l

0.69

113

393

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

307

0.19

9.67

1.3

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

305

0.19

9.51

1.2

1.3

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

305

0.19

9.51

1.2

1.3

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

306

0.19

9.49

1.3

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

261

0.15

9.46

1.5

1.3

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

265

2.15

9.43

1.1

—

(3005033) Fetal Nuchal fold Thickness US

259

0.15

9.30

1.3

—

(3046861) Legionella sp Ag [Presence] in Urine

8.59

9.26

1.0

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

115

392

1.93

9.26

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

115

392

1.93

9.26

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

115

392

1.93

9.26

1.2

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

396

1845

1.42

9.22

1.7

1.8

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

748

0.40

9.19

1.5

1.3

135.60

185.77

pmol/l

1.78

748

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

114

389

1.92

9.15

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

114

389

1.92

9.15

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

114

389

1.92

9.15

1.2

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

146

2.56

9.04

1.1

1.3

37.79

40.93

g/l

0.64

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

166

2.45

9.00

1.7

2.0

24.77

50.62

u/l

0.93

147

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

324

1465

1.46

8.88

1.1

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

184

735

1.65

8.76

3.3

3.7

12.61

12.30

nmol/l

0.01

177

719

(40768800) Prostate Pathology biopsy report

160

1707

0.61

8.71

1.2

—

(3006270) Folate [Moles/volume] in Blood

118

415

1.87

8.69

1.2

1.1

311.57

363.07

nmol/l

2.05

362

(3029075) Extractable nuclear Ab panel - Serum

144

2.50

8.39

1.1

—

(3011436) Histone Ab [Units/volume] in Serum

100

2.82

8.19

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

121

1354

0.58

8.01

1.9

2.0

—

(3044009) aPTT.lupus sensitive (LA screen)

4.14

7.98

1.2

1.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

161

1668

0.63

7.78

1.9

2.0

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

168

678

1.63

7.74

1.8

2.3

689.05

3192.21

u/l

1.72

262

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

642

3316

1.28

7.60

1.2

110.95

159.81

iu/ml

2.71

218

1240

(3021162) Amylase [Enzymatic activity/volume] in Specimen

105

2.68

7.53

2.6

2.9

2938.59

1049.48

u/l

0.59

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

113

2.61

7.49

2.5

2.4

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

6.91

7.47

1.1

1.0

—

(3020961) Endomysium IgA Ab [Titer] in Serum

496

2485

1.32

7.39

1.1

259.36

276.00

titre

0.03

(3003338) MCHC [Mass/volume]

8542

53738

1.11

7.33

45.5

12.6

328.47

332.99

g/l

298.72

8471

53313

(3050794) Legionella sp Ab [Presence] in Serum

3.62

7.32

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

181

2.21

7.15

1.1

1.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

100

357

1.84

7.12

1.4

—

(3028717) Thiamine [Mass/volume] in Blood

4.00

7.05

1.3

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

117

2.52

7.02

1.2

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

259

1179

1.45

6.95

1.7

351.70

289.21

mu/l

1.80

232

1085

(3020393) Adenovirus Ag [Presence] in Stool

3.22

6.91

1.3

1.2

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

134

2.40

6.90

1.2

0.34

0.30

g/l

3.05

108

(3051387) C reactive protein [Mass/volume] in Capillary blood

261

1194

1.44

6.83

6.1

2.6

25.63

28.20

mg/l

0.55

185

733

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

410

3508

0.76

6.82

1.6

1.8

—

(3016018) Differential panel - Cerebral spinal fluid

153

625

1.61

6.78

1.6

1.5

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

194

839

1.52

6.72

1.0

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

4.53

6.67

1.0

1.2

2.33

1.37

umol/24h

1.94

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

346

1.82

6.66

1.2

1.4

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

3.79

6.60

1.1

—

(3045462) Protein/Creatinine [Ratio] in Urine

3.93

6.59

4.5

4.2

70.06

15.34

g/mol

0.84

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

306

1451

1.39

6.56

1.5

1.3

528.73

583.31

mg/l

0.64

293

1369

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

272

1264

1.42

6.55

1.4

1.3

4.40

3.60

mmol/l

12.39

258

1187

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

327

1569

1.37

6.53

1.3

1.4

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

6.98

6.43

10.3

7.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

102

379

1.77

6.42

1.3

1.4

0.92

2.02

u/ml

0.71

221

(21494567) Legionella sp IgM Ab [Presence] in Serum

3.69

6.38

1.1

—

(3006462) Nitrate [Presence] in Urine

244

1.96

6.36

4.3

2.8

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

258

1.93

6.33

1.3

1.2

53.10

69.11

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

144

2.28

6.32

1.8

1.6

10.34

8.86

ug/l

1.24

144

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

343

1.80

6.29

1.2

1.4

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.90

6.29

1.7

1.5

—

(40761895) Polymorphonuclear cells/100 leukocytes in Peritoneal dialysis fluid

+∞

6.14

2.7

0.0

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

126

2.34

6.07

1.0

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.82

6.00

1.2

1.6

—

(3042951) Complement C1q Ab [Units/volume] in Serum

7.64

5.99

1.6

1.0

32.98

—

u/ml

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

2.92

5.97

5.3

3.1

1.79

1.01

mg/l

0.93

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

150

2.18

5.79

1.6

0.49

0.34

ug/l

1.14

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

387

0.35

5.74

1.2

1.3

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

3.64

5.71

2.0

1.0

26.27

19.72

mmol/l

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

130

2.27

5.69

1.0

1.1

—

(3018133) Calcium [Moles/volume] in Urine

2.59

5.66

1.6

1.9

2.23

2.85

mmol/l

0.74

(3000060) B lymphocytes [#/volume] in Blood

143

2.20

5.65

2.1

2.2

160.74

410.63

e6/l

0.51

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

265

1.86

5.60

1.8

1.7

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

13.09

5.57

1.0

1.2

—

mmol/l

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

3.35

5.37

1.0

1.3

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

138

2.18

5.35

1.1

1.3

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

263

1262

1.37

5.34

1.4

21.67

25.06

e6/l

0.14

210

972

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

263

1263

1.37

5.31

1.5

945.67

1825.24

e6/l

0.83

225

1018

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

128

2.20

5.11

1.2

112.39

107.14

0.64

118

(3013166) Neutrophils/100 leukocytes in Synovial fluid

150

2.10

5.07

1.3

73.77

51.53

4.88

131

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

133

2.17

5.05

1.0

1.1

—

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

7.14

5.02

2.9

1.5

597.57

142.82

umol/l

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

117

2.24

4.96

1.2

1.1

—

(4212803) Bone marrow aspirate examination

3.06

4.93

1.2

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

182

836

1.43

4.80

1.2

1.3

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

264

0.30

4.74

1.5

—

(3044290) Cell count panel - Cerebral spinal fluid

250

1215

1.35

4.73

1.6

1.4

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.81

4.67

1.0

1.1

—

(3009015) Lactate [Moles/volume] in Synovial fluid

2.73

4.63

1.1

1.3

6.61

6.80

mmol/l

0.05

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

134

2.10

4.61

1.2

1.1

—

(40765096) Chromosome analysis panel by Banding

179

1.94

4.59

1.0

1.2

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

8.18

4.58

1.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

3.61

4.55

1.1

1.0

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

3.61

4.55

1.0

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

203

1.87

4.54

3.1

3.4

—

(40768795) Lymph node Pathology biopsy report

157

715

1.44

4.37

1.2

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

2.36

4.36

4.2

4.0

38.77

44.55

umol/l

0.62

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

2.98

4.31

1.5

1.1

13.00

23.00

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

10.47

4.18

1.1

1.2

—

(3051101) Glucose [Moles/volume] in Cord blood

2.91

4.16

5.6

5.7

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

172

1.90

4.15

1.3

1.2

45.50

15.61

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

373

1.60

4.15

1.5

1.7

—

(3026470) Cobalt [Mass/volume] in Blood

374

1.60

4.11

2.0

4.92

3.55

ug/l

0.34

340

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

2.47

4.02

1.1

1.0

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

124

2.06

4.02

1.0

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

133

2.02

4.01

1.0

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

198

1.82

3.99

2.8

3.2

29.97

27.59

umol/l

0.65

152

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

7.36

3.95

4.9

1.0

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

209

1.79

3.91

2.6

2.5

143.14

149.94

nmol/l

0.18

174

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

586

0.58

3.77

1.0

0.06

0.56

u/ml

1.00

159

(3019420) Tryptase [Mass/volume] in Serum or Plasma

272

1.66

3.70

1.8

1.6

13.05

9.05

ug/l

0.31

251

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.41

3.70

1.4

1.6

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

2.27

3.53

1.5

1.3

57.80

61.66

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

130

0.25

3.50

1.0

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.34

3.50

1.1

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

2.85

3.46

1.5

1.4

0.60

1.09

mg/l

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.85

3.46

1.4

1.1

11.71

12.15

u/l

0.03

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

4.13

3.45

2.2

1.2

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

278

1440

1.27

3.43

1.1

21.97

8.74

u/ml

0.65

197

(3014133) Dog dander IgE Ab [Units/volume] in Serum

698

0.64

3.40

1.1

5.86

3.08

u/ml

0.51

318

(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma

7.63

3.23

1.1

2.5

38.43

23.00

umol/l

—

(3025577) Chromium [Mass/volume] in Blood

366

1.52

3.23

2.1

2.0

2.41

2.51

ug/l

0.08

312

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

2.83

3.22

1.6

1.4

0.31

2.03

mg/l

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

2.83

3.22

1.6

1.4

0.65

2.89

mg/l

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

2.83

3.22

1.6

1.4

0.35

0.54

mg/l

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

2.83

3.22

1.6

1.4

0.33

3.07

mg/l

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

2.83

3.22

1.6

1.4

3.53

4.02

mg/l

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

2.83

3.22

1.6

1.4

0.40

0.96

mg/l

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

2.83

3.22

1.6

1.4

2.46

2.93

mg/l

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

2.83

3.22

1.6

1.4

1.34

1.00

mg/l

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

2.83

3.22

1.6

1.4

4.35

2.70

mg/l

—

(3011325) HIV 1+2 Ab [Presence] in Serum

3.54

3.21

1.1

1.0

—

(3000285) Sodium [Moles/volume] in Blood

2.49

3.04

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.08

3.04

1.3

1.5

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.18

3.04

1.0

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

559

0.62

3.03

1.0

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

111

1.95

3.01

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.29

2.97

1.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

658

0.65

2.93

1.1

7.21

4.08

u/ml

0.32

257

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

3.41

2.90

1.1

1.0

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

3.41

2.90

1.0

37.18

36.40

0.25

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

3.41

2.90

1.0

19.47

22.88

1.70

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.08

2.82

1.5

1.6

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

125

0.31

2.76

9.0

5.6

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

125

0.31

2.76

4.5

2.8

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

153

1.75

2.76

1.2

1.4

155.41

139.71

nmol/l

0.12

108

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

174

1461

0.78

2.74

1.4

1.5

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.55

2.71

1.1

1.3

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

186

0.39

2.68

1.2

1.5

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

215

1.61

2.65

1.2

1.1

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

3.63

2.65

1.2

1.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.69

2.62

1.6

1.3

—

(3023410) Appearance of Cerebral spinal fluid

123

595

1.36

2.58

1.7

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.62

2.50

1.0

1.3

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.18

2.47

2.2

0.70

0.62

u/field

0.15

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

3.27

2.40

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.54

2.38

1.1

1.0

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.01

2.33

1.0

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.22

2.33

4.7

6.9

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.96

2.30

2.1

1.9

13.87

18.59

umol/l

1.28

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.08

2.22

1.0

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

823

0.74

2.21

1.1

1.19

1.76

u/ml

0.49

394

(40762887) Creatinine [Moles/volume] in Blood

4.91

2.20

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

4.91

2.20

1.5

1.1

2.50

3.50

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

229

0.51

2.13

1.6

1.7

—

(3025130) Human papilloma virus identified in Specimen

641

0.71

2.08

2.1

1.7

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.82

2.07

1.1

1.0

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

512

2957

1.14

2.05

3.2

3.9

80.44

62.88

u/ml

0.67

491

2861

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.96

2.04

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

163

1.61

2.04

1.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

4.36

2.03

1.0

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

260

1.46

1.95

1.0

1.1

5.19

7.49

u/ml

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

2.57

1.92

1.1

1.0

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

104

519

1.31

1.87

1.3

1.4

28.57

34.84

u/l

1.02

424

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.09

1.84

1.0

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.09

1.84

1.0

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

128

1.64

1.78

1.0

1.1

—

(3001729) Color of Synovial fluid

2.18

1.78

1.6

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

1.76

0.0

1.0

—

(40762814) Titanium [Mass/volume] in Blood

114

1.66

1.73

2.3

3.59

4.31

ug/l

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

510

0.72

1.68

1.0

253.86

343.29

ng/l

2.61

390

(3018291) Platelet Ab [Presence] in Serum

4.09

1.68

1.2

1.3

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

2.04

1.65

1.1

1.5

0.12

0.17

nmol/l

—

(3016135) IgD [Mass/volume] in Serum

3.27

1.61

5.2

2.0

39.22

401.93

mg/l

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

132

1.59

1.61

1.6

1.4

3.47

4.02

umol/l

0.36

124

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.86

1.59

1.0

1.2

232.86

213.25

nmol/l

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

317

1.36

1.58

1.1

7.93

3.37

nmol/l

0.32

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.00

1.57

1.0

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

517

0.73

1.55

1.0

817.68

735.84

ng/l

0.74

377

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

516

0.73

1.53

1.0

37.67

42.69

ng/l

0.62

390

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

470

0.72

1.52

1.1

1.3

1.50

1.57

g/l

0.83

470

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

3.02

1.50

1.0

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

3.02

1.50

1.2

1.0

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

2.07

1.49

1.8

1.9

1.38

1.29

umol/l

0.64

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1268

8815

0.93

1.49

1.4

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.34

1.48

1.0

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

218

1220

1.17

1.44

1.5

1.4

255.19

150.09

pmol/l

1.13

211

1193

(3012494) Peanut IgE Ab [Units/volume] in Serum

131

1.55

1.44

1.0

1.1

0.46

1.84

u/ml

1.06

(3003740) Influenza virus B Ag [Presence] in Specimen

110

891

0.81

1.43

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

329

1.33

1.42

1.1

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

3.27

1.41

1.0

—

(3030313) Adrenal Ab [Titer] in Serum

2.26

1.39

1.2

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.26

1.39

1.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

1.95

1.39

1.0

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.84

1.35

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

284

0.67

1.35

1.2

1.3

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

2.12

1.33

5.2

5.5

—

(3042517) Benzodiazepines panel - Urine

2.18

1.32

2.0

3.3

—

(3002523) Influenza virus A Ag [Presence] in Specimen

111

888

0.82

1.31

1.1

—

(3011288) Drugs identified in Urine by Screen method

164

905

1.19

1.31

4.1

2.9

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

221

1665

0.87

1.31

1.5

1.3

23.97

37.15

iu/l

6.21

176

1414

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

2.62

1.30

1.2

1.1

—

(3015183) Erythrocyte sedimentation rate

311

0.69

1.27

1.4

1.2

—

(3041672) Baker's yeast Ab [Presence] in Serum

2.28

1.24

1.0

1.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.28

1.24

1.0

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

157

869

1.18

1.23

1.1

—

11.27

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.74

1.23

1.0

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

414

0.74

1.22

1.1

—

(40760409) HLA-A [Type] by High resolution

2.18

1.19

1.0

—

(46236302) HLA-C [Type] by High resolution typing

2.18

1.19

1.0

—

(40763590) HLA-DQ beta [Type]

2.18

1.19

1.0

—

(40760410) HLA-B [Type] by High resolution

2.18

1.19

1.0

—

(3008898) HLA-B27 [Presence]

240

1783

0.88

1.19

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

300

1.31

1.17

1.7

1.6

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

182

1.40

1.17

1.2

1.1

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

290

1.31

1.14

14.5

11.8

0.65

0.62

mmol/l

0.39

267

(3028679) Herpes simplex virus Ab [Presence] in Serum

274

1.31

1.11

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

100

0.52

1.06

1.3

2.3

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.98

1.06

1.1

1.3

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.89

1.04

1.4

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.90

1.00

1.1

1.3

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

113

874

0.84

1.00

1.0

1.1

0.96

1.52

u/ml

0.56

371

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

627

4393

0.93

0.99

2.3

2.4

24.52

24.37

au/ml

0.01

382

(1001926) Buprenorphine [Presence] in Urine by Screen method

198

1139

1.14

0.99

2.4

2.0

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

569

3998

0.93

0.98

1.3

35.56

53.33

au/ml

1.21

255

(3013862) HLA-DP [Type]

2.01

0.91

1.0

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

1.57

0.89

1.2

1.1

120.44

83.21

ug/l

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

118

898

0.86

0.88

1.0

1.1

7.83

4.30

u/ml

0.71

458

(44813793) Dust mix specific IgE antibody measurement

364

1.22

0.83

1.0

1.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.74

0.82

1.0

1.1

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.81

0.0

1.4

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.52

0.81

1.1

—

(3006598) pH of Arterial cord blood

0.00

0.80

0.0

1.0

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

396

1.21

0.80

1.2

1.1

242.22

310.51

mg/l

1.82

350

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.18

0.76

1.0

1.1

—

(3017509) Phencyclidine [Presence] in Urine

1.64

0.75

1.7

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

625

3860

1.06

0.74

1.2

—

(3022725) Serotonin [Moles/volume] in Serum

2.04

0.73

1.2

1.1

923.40

1608.94

nmol/l

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

1.76

0.71

1.0

1.9

2.33

3.90

nmol/l

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

137

1011

0.88

0.71

1.1

1.94

1.44

u/ml

0.16

507

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

348

1.20

0.70

1.0

1.1

9.76

9.21

iu/ml

0.07

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

277

1969

0.92

0.70

1.9

1.7

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

1.40

0.69

1.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

138

1.33

0.68

1.7

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

311

0.80

0.66

1.1

1.0

0.31

1.74

u/ml

1.50

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

220

1.25

0.66

1.0

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

315

1.20

0.66

4.9

6.5

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

105

1.37

0.65

1.2

1.8

2.32

3.38

ug/l

0.87

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.69

0.64

1.3

—

(3007542) Rye IgE Ab [Units/volume] in Serum

1.72

0.62

1.0

1.1

—

1.27

u/ml

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

159

937

1.11

0.62

1.4

1.2

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.62

0.0

1.0

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

414

1.17

0.62

1.3

1.1

39.38

46.43

mg/l

0.55

346

(3015076) Soybean IgE Ab [Units/volume] in Serum

279

0.80

0.62

1.1

1.0

0.25

1.63

u/ml

0.58

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.56

0.60

1.1

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.38

0.60

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.38

0.60

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.38

0.60

1.2

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.78

0.59

1.2

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.60

0.59

1.0

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

1.45

0.57

1.1

1.0

1.40

0.23

u/ml

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

418

1.16

0.56

1.6

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

240

1452

1.08

0.56

2.0

1.8

188.68

218.87

pmol/l

3.75

228

1401

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

416

0.85

0.55

1.1

1.2

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.44

0.52

1.0

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

127

1.29

0.52

1.1

—

(40768793) Breast Pathology biopsy report

204

1440

0.93

0.50

1.3

—

(1002224) Polysomnography panel

368

2275

1.06

0.49

1.0

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

0.68

0.47

1.0

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

323

0.85

0.44

1.0

0.75

2.79

u/ml

1.01

101

(3025018) Bordetella pertussis Ab [Titer] in Serum

312

1.15

0.43

1.2

1.3

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

239

1.18

0.43

1.0

1.1

459.77

319.73

ng/l

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.71

0.42

1.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.42

0.0

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.45

0.42

2.0

1.5

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

200

0.82

0.41

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.38

0.39

1.0

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

389

1.13

0.39

1.2

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

133

1.23

0.39

1.2

—

(3001556) Androgen free Index in Serum or Plasma

1.42

0.39

1.2

1.4

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.42

0.39

1.2

1.7

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.42

0.39

1.0

—

(3020650) Glucose [Presence] in Urine

140

1.21

0.37

2.3

1.3

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

311

2136

0.95

0.37

1.8

1.7

39.01

44.39

nmol/l

3.71

298

2094

(3005011) Chlamydia sp Ab [Titer] in Serum

1.29

0.37

1.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

2190

14085

1.02

0.36

2.7

2.8

0.72

0.74

ug/l

0.27

1545

8653

(3027944) Amphetamines [Presence] in Urine

218

1511

0.94

0.36

2.5

1.9

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.40

0.35

1.2

1.6

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.39

0.35

2.4

2.5

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

170

1179

0.94

0.31

4.1

3.6

31.07

41.77

u/ml

1.03

159

1144

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

449

1.09

0.28

4.4

4.9

31.27

120.91

u/ml

2.36

142

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

1.28

0.28

9.5

5.6

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.25

0.27

1.9

2.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

146

1.16

0.26

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

270

1.11

0.26

1.6

1.2

—

(3027008) Opiates [Presence] in Urine

226

1542

0.96

0.24

2.4

1.9

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.75

0.23

1.0

1.3

—

(3028300) Cannabinoids [Presence] in Urine

227

1544

0.96

0.22

2.5

1.9

—

(3032641) Amino acids panel - Urine

0.00

0.22

0.0

1.1

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.22

0.0

6.6

—

0.18

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.22

0.0

1.0

—

2.03

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

0.22

0.0

1.0

—

166.88

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

609

1.06

0.21

1.2

8.07

6.83

mmol/l

3.51

507

(3045683) HLA typing for celiac disease panel - Blood or Tissue

356

0.92

0.21

1.0

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

130

0.85

0.20

1.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.23

0.20

1.3

1.2

442.83

360.41

umol/24h

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.23

0.20

1.0

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

150

1.13

0.20

2.7

2.5

66.89

120.65

ng/l

1.34

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

129

0.86

0.19

2.2

2.8

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

163

0.88

0.18

1.6

1.8

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

217

0.90

0.17

1.5

52.14

5.83

ug/l

0.41

133

(3017446) Testosterone [Moles/volume] in Serum or Plasma

841

5587

0.98

0.17

2.5

2.0

11.10

14.47

nmol/l

27.97

723

5134

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

196

0.90

0.17

3.2

3.5

9.81

8.15

mg/l

0.40

163

(3000764) Benzodiazepines [Presence] in Urine

227

1530

0.97

0.16

2.4

1.9

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

178

1.10

0.16

1.5

1.4

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.15

0.15

1.0

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

114

778

0.96

0.15

1.1

5.65

4.67

u/ml

0.15

363

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.11

0.15

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.83

0.14

3.5

2.3

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

131

1.10

0.11

1.1

1.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

364

2420

0.98

0.10

4.1

1.4

6.26

3.10

mg/l

4.67

342

1598

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.14

0.09

14.5

4.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

506

1.03

0.08

1.4

0.22

0.24

nmol/l

0.29

359

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.04

0.08

1.3

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

161

0.93

0.07

1.3

1.4

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.83

0.07

1.0

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.09

0.07

1.6

2.7

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.09

0.07

1.8

2.7

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

1.09

0.07

1.2

1.1

6.51

8.83

mg/g

1.19

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

433

2804

1.01

0.06

1.1

1.0

—

(3016879) Cocaine [Presence] in Urine

222

1432

1.01

0.06

2.5

1.9

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

179

0.95

0.05

2.7

2.9

70.50

189.17

au/ml

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

322

0.97

0.03

1.2

1.5

—

(46235168) Fasting glucose [Moles/volume] in Blood

1.07

0.03

1.7

1.1

8.71

5.68

mmol/l

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

517

1.01

0.01

1.1

—

(40758292) HTLV I+II Ab panel - Serum

126

1.04

0.01

1.6

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

378

0.99

0.01

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.95

0.01

1.0

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

292

0.99

0.00

1.1

1.17

u/l

0.01

167

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.05

0.00

1.0

—

(3011897) Casein IgE Ab [Units/volume] in Serum

1.01

0.00

1.0

1.3

0.05

0.68

u/ml

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

138

1.00

0.00

1.0

1.1

11.51

10.83

u/ml

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

401

0.99

0.00

5.4

6.3

407.45

7790.55

u/ml

0.49

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3013762) Body weight Measured

1.02

-0.00

1.0

1.3

—

(3029847) von Willebrand factor (vWf).collagen binding activity actual/normal in Platelet poor plasma by Immunoassay

0.00

-0.00

0.0

1.7

—

68.17

—

(40759632) Porphyrins [Mass/mass] in Stool

0.00

-0.00

0.0

1.2

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.84

-0.00

1.0

1.1

—

(3022670) pH of Venous cord blood

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint I9_HEARTFAIL_AND_ANTIHYPERT and mortality.

Females

Parameter	HR [95% CI]	p-value
I9_HEARTFAIL_AND_ANTIHYPERT	1.736 [1.61, 1.87]	< 0.001
Birth year	0.992 [0.98, 1.0]	0.027

During the follow-up period (1.1.1998 — 31.12.2019), 86852 out of 140848 females with I9_HEARTFAIL_AND_ANTIHYPERT died.

Males

Parameter	HR [95% CI]	p-value
I9_HEARTFAIL_AND_ANTIHYPERT	2.193 [2.01, 2.39]	< 0.001
Birth year	0.985 [0.98, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 75839 out of 127018 males with I9_HEARTFAIL_AND_ANTIHYPERT died.

Mortality risk

Mortality risk for people of age

years, who have I9_HEARTFAIL_AND_ANTIHYPERT.

N-year risk	Females	Males
1	0.118%	0.378%
5	0.829%	2.13%
10	2.101%	5.094%
15	3.707%	9.263%
20	6.318%	14.907%

Relationships between endpoints

↥

Index endpoint: I9_HEARTFAIL_AND_ANTIHYPERT – Heart failure and antihypertensive medication

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Heart failure and antihypertensive medication

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints